WO2011113718A1 - Composition containing a dibenzoylmethane screening agent and a hydrophilic or water-soluble merocyanin uv-screening agent; process for photostabilizing the dibenzoylmethane screening agent - Google Patents

Composition containing a dibenzoylmethane screening agent and a hydrophilic or water-soluble merocyanin uv-screening agent; process for photostabilizing the dibenzoylmethane screening agent Download PDF

Info

Publication number
WO2011113718A1
WO2011113718A1 PCT/EP2011/053376 EP2011053376W WO2011113718A1 WO 2011113718 A1 WO2011113718 A1 WO 2011113718A1 EP 2011053376 W EP2011053376 W EP 2011053376W WO 2011113718 A1 WO2011113718 A1 WO 2011113718A1
Authority
WO
WIPO (PCT)
Prior art keywords
derivatives
radicals
chosen
compounds
acid
Prior art date
Application number
PCT/EP2011/053376
Other languages
French (fr)
Inventor
Hervé Richard
Benoit Muller
Original Assignee
L'oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR1051823A external-priority patent/FR2957250B1/en
Priority claimed from FR1059756A external-priority patent/FR2967900B1/en
Application filed by L'oreal filed Critical L'oreal
Priority to CN2011800240512A priority Critical patent/CN102883704A/en
Priority to EP11706614A priority patent/EP2547313A1/en
Priority to US13/634,194 priority patent/US9162976B2/en
Priority to JP2012557477A priority patent/JP2013522259A/en
Priority to BR112012023232-0A priority patent/BR112012023232B1/en
Publication of WO2011113718A1 publication Critical patent/WO2011113718A1/en
Priority to US14/845,342 priority patent/US20160058682A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/30—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/30—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same unsaturated acyclic carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/31—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/07—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton
    • C07C309/12—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton containing esterified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • C07C309/15—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton the nitrogen atom of at least one of the amino groups being part of any of the groups, X being a hetero atom, Y being any atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/20—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • C07C309/22—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton containing carboxyl groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/23—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/10—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Definitions

  • the present invention relates to a cosmetic composition containing a combination i) of at least one screening agent of the dibenzoylmethane derivative type and ii) of at least one particular hydrophilic or water-soluble merocyanin UV-screening agent, the definition of which will be given below.
  • the invention also relates to a process for the radiation-photostabilization of at least one screening agent of the dibenzoylmethane derivative type with an effective amount of at least one particular hydrophilic or water-soluble merocyanin UV-screening agent, the definition of which will be given below.
  • UV-B radiation It is known that light radiation with wavelengths of between 280 nm and 400 nm permits tanning of the human epidermis and that light rays with wavelengths more particularly between 280 and 320 nm, known as UV-B rays, cause skin burns and erythema which can harm the development of a natural tan. For these reasons, and also for aesthetic reasons, there is constant demand for means for controlling this natural tanning in order thus to control the colour of the skin; this UV-B radiation should thus be screened out.
  • UV-A rays with wavelengths between 320 and 400 nm, which cause tanning of the skin, are liable to induce adverse changes therein, in particular in the case of sensitive skin or skin that is continually exposed to solar radiation.
  • UV-A rays cause in particular a loss of elasticity of the skin and the appearance of wrinkles leading to premature ageing of the skin. They promote triggering of the erythemal reaction or amplify this reaction in certain individuals and may even be the cause of phototoxic or photoallergic reactions.
  • people increasingly wish to control the effect of UV-A rays on their skin. It is thus desirable also to screen out UV-A radiation.
  • antisun compositions comprising organic screening agents that are active in the UV-A range and in the UV-B range are generally used.
  • the majority of these screening agents are liposoluble.
  • one particularly advantageous family of UV-A screening agents currently consists of dibenzoylmethane derivatives, and in particular 4-tert-butyl- 4'-methoxydibenzoylmethane, which have high intrinsic absorbing power.
  • dibenzoylmethane derivatives which are products that are now well known per se as screening agents that are active in the UV-A range, are described in particular in French patent applications FR-A-2 326 405 and FR-A-2 440 933, and also in European patent application EP-A-0 1 14 607; 4-tert-butyl-4'- methoxy-dibenzoylmethane is moreover currently sold under the trade name Parsol 1789® by the company DSM Nutritional Products.
  • dibenzoyl-methane derivatives are products that are relatively sensitive to ultraviolet radiation (especially UV-A), i.e., more specifically, they have an annoying tendency to be degraded more or less quickly under the action of this radiation.
  • Patent application WO 01/28732 discloses a process for photostabilizing a dibenzoylmethane derivative with a merocyanin phenyl sulfone derivative. Firstly, this photostabilization of the dibenzoylmethane derivative with the merocyanin phenyl sulfone derivative is not entirely satisfactory. Secondly, these merocyanin phenyl sulfone derivatives have the drawback of being degraded in the presence of dibenzoylmethane under the influence of UV radiation.
  • Patent application WO 2008/090 066 has already proposed photostabilizing dibenzoylmethane derivatives with cyclic merocyanin cyanoacetate derivatives.
  • the photostabilization of the dibenzoylmethane derivative remains insufficient and these merocyanin cyanoacetate derivatives also have the drawback of being degraded in the presence of dibenzoylmethane.
  • the photostabilization of dibenzoylmethane derivatives towards UV radiation thus constitutes, at the present time, a problem that has still not been solved entirely satisfactorily.
  • the Applicant has now discovered, surprisingly, that by combining the dibenzoylmethane derivatives mentioned above with a particular hydrophilic or water-soluble merocyanin UV-screening agent, the definition of which will be given later, which are active in the UV-A range, it is possible firstly to substantially improve the photochemical stability (or photostability) of the dibenzoylmethane derivatives and, secondly, to extend the filtration of the composition in the longer UV-A range while at the same time giving cosmetically acceptable coloration.
  • composition comprising, in a cosmetically acceptable support, at least one UV-screening system, characterized in that it comprises:
  • Another subject of the invention also concerns a process for improving the chemical stability towards UV radiation of at least one dibenzoylmethane derivative, which consists in combining the said dibenzoylmethane derivative with an effective amount of at least one particular hydrophilic or water-soluble merocyanin UV-screening agent, the definition of which will be given below.
  • cosmetically acceptable means compatible with the skin and/or its integuments, which has a pleasant colour, odour and feel, and which does not cause any unacceptable discomfort (stinging, tautness or redness) liable to dissuade the consumer from using this composition.
  • hydrophilic UV-screening agent means any agent for screening out UV radiation, which may be soluble in an aqueous phase at 1 -5% by weight (transparent) or water-dispersible in the form of a suspension of particles smaller than 100 microns.
  • water-soluble screening agent means any agent for screening out UV radiation, which may be soluble in its cosmetically acceptable salt form in an aqueous phase at more than 5% by weight.
  • the term "effective amount” means an amount that is sufficient to obtain a notable and significant improvement in the photostability of the dibenzoylmethane derivative(s) in the cosmetic composition.
  • This minimum amount of merocyanin derivatives according to the invention which may vary according to the nature of the support adopted for the composition, may be determined without any difficulty by means of a standard test for measuring photostability, such as the test given in the examples hereinbelow.
  • dibenzoylmethane derivatives that may especially be mentioned, in a non-limiting manner, are:
  • the dibenzoylmethane derivative(s) may be present in the compositions in accordance with the invention in contents preferably ranging from 0.01 % to 20% by weight, more preferentially from 0.1 % to 10% by weight and even more preferentially from 0.1 % to 6% by weight relative to the total weight of the composition.
  • hydrophilic or water-soluble merocyanin compounds in accordance with the invention are chosen from the group formed by:
  • Ri and R2 which may be identical or different, represent H; a linear or branched C1-C22 alkyl radical possibly containing from 1 to 3 oxygen atoms; a C3-C8 cycloalkyl radical, which is unsubstituted or substituted with Ci-C 4 alkyl radicals; the said radicals Ri and R2 possibly containing an alkylsulfonate radical in its acid or salified form or one or two hydroxyl radicals;
  • - Ri and R2 may form, together with the nitrogen, a ring containing the group - (CH 2 ) m -, which is uninterrupted or interrupted with one or more -O-, -S- or -NH-, - Ri may form, with the carbon alpha to the nitrogen, a ring containing the group -(CH 2 ) m -, which is uninterrupted or interrupted with one or more -O-, -S- or -NH-,
  • - R 3 represents a carboxyl, -COOR5, -CONHR5, -COR5, -CONR5R1 , SO 2 R 5 , or - CN group,
  • R 4 represents a carboxyl, -COOR 6 , -CONHR 6 , -COR 6 , -CONR 6 R 2 or SO 2 R 6 group,
  • R 5 and R6 which may be identical or different, represent a linear or branched Ci-C 22 alkyl radical possibly containing from 1 to 3 oxygen atoms; a C3-C8 cycloalkyi radical, which is unsubstituted or substituted with Ci-C 4 alkyl radicals; the said radicals R 5 and R6 possibly containing an alkylsulfonate radical in its acid or salified form or one or two hydroxyl radicals,
  • - Z represents the group -(CH 2 )i- , which is uninterrupted or interrupted with -O-, -S- or -NR 7 -, and/or unsubstituted or substituted with one or two C1-C6 alkyl radicals,
  • R 7 is a C1-C5 alkyl radical possibly containing an alkylsulfonate radical in its acid or salified form or one or two hydroxyl radicals,
  • Ri and R 2 are not simultaneously a hydrogen atom
  • the merocyanin compounds of the invention may be in the ⁇ , ⁇ -, ⁇ , ⁇ - or ⁇ , ⁇ - geometrical isomer forms.
  • diradical means a divalent radical such that the two units
  • linear or branched alkyl radicals examples include: methyl, ethyl, n-propyl, isopropyl, 1 -methylethyl, butyl, pentyl, hexyl, 2- ethyl hexyl, octyl, 1 -methylheptyl.
  • C3-C8 cycloalkyl radicals that may be mentioned include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, 1 -methylcyclopropyl, 1 -ethylcyclopropyl, 1 -propylcyclopropyl, 1 -butylcyclopropyl, 1 -methyl-1 -butylcyclopropyl, 1 ,2-dimethylcyclypropyl, 1 -methyl-2-ethylcyclopropyl and cyclooctyl.
  • the acceptable salts of the merocyanin compounds described in the present invention comprise conventional non-toxic salts of the said compounds, such as those formed from organic or mineral bases, such as amine salts, for instance salts of alkanolamines such as triethanolamine, amino acid salts or aminopropanediol salts, and salts of an alkali metal or alkaline-earth metal, for instance sodium or potassium.
  • amine salts for instance salts of alkanolamines such as triethanolamine, amino acid salts or aminopropanediol salts, and salts of an alkali metal or alkaline-earth metal, for instance sodium or potassium.
  • the preferred salts are salts of an alkali metal such as sodium or potassium, or salts of an amine such as triethanolamine.
  • Ri denotes hydrogen; a linear or branched Ci-Cs alkyl radical possibly containing from 1 to 3 oxygen atoms,
  • R2 denotes a linear or branched Ci-Cs alkyl radical possibly containing from 1 to
  • R 3 denotes a group -COOR 5 , -CN or -CONHR 5 ,
  • R 4 denotes a group -COOR 6 , -CONHR 6 or -SO 2 R 6 ,
  • R 5 denotes a linear or branched C1-C12 alkyl radical possibly containing from 1 to 3 oxygen atoms
  • n is equal to 1 or 2;
  • Ri denotes hydrogen; a linear or branched C1-C10 alkyl radical possibly containing from 1 to 3 oxygen atoms,
  • R2 denotes a linear or branched C1-C10 alkyl radical possibly containing from 1 to 3 oxygen atoms; a C5-C6 cycloalkyl,
  • R3 denotes a group -COOR5 or CN
  • R 4 denotes a group -COOR6 or -SO2R6,
  • R 5 denotes a linear or branched C1-C12 alkyl radical possibly containing from 1 to 3 oxygen atoms
  • Z is -(CH 2 )3- which may or may not be substituted with two groups CH 3 , n is equal to 1 or 2;
  • linear merocyanin derivatives in accordance with the invention in particular those of formula (I), may be prepared according to a method described in patents US 4 045 229, US 4 195 999 and US 2009/0 170 008 according to the following scheme (route 1 ):
  • cyclic merocyanin derivatives in accordance with the invention in particular those of formula (II), may be prepared according to a method described in IP.COM Journal 9(5A), 29-30 (2009) according to the following scheme:
  • hydrophilic or water-soluble merocyanin compounds in accordance with the invention are novel and constitute another subject of the invention.
  • hydrophilic or water-soluble merocyanin screening agent(s) in accordance with the invention may be present in the compositions according to the invention in a concentration of between 0.1 % and 10% and preferably between 0.2% and 5% by weight relative to the total weight of the composition.
  • compositions in accordance with the invention may also comprise other additional UVA-active and/or UVB-active organic or mineral UV-screening agents that are water-soluble or liposoluble or even insoluble in the cosmetic solvents commonly used.
  • the additional organic screening agents are chosen especially from anthranilates; cinnamic derivatives; salicylic derivatives; camphor derivatives; benzophenone derivatives; , diphenylacrylate derivatives; triazine derivatives other than those of formula (II); benzotriazole derivatives; benzalmalonate derivatives, especially those mentioned in patent US 5 624 663; benzimidazole derivatives; imidazolines; bis-benzazolyl derivatives as described in patents EP 669 323 and US 2 463 264; p-aminobenzoic acid (PABA) derivatives; methylenebis(hydroxyphenylbenzotriazole) derivatives as described in patent applications US 5 237 071 , US 5 166 355, GB 2 303 549, DE 197 26 184 and EP 893 1 19; benzoxazole derivatives as described in patent applications EP 0 832 642, EP 1 027 883, EP 1 300 137 and DE 101 62 844; screening polymers and
  • organic UV-screening agents mention may be made of those denoted hereinbelow under their INCI name: para-aminobenzoic acid derivatives:
  • Ethylhexyl dimethyl PABA sold in particular under the name Escalol 507 by ISP, Glyceryl PABA,
  • PEG-25 PABA sold under the name Uvinul P25 by BASF, Salicylic derivatives:
  • Ethylhexyl salicylate sold under the name Neo Heliopan OS by Symrise,
  • TEA salicylate sold under the name Neo Heliopan TS by Symrise
  • Ethylhexyl methoxycinnamate sold especially under the trade name Parsol MCX by DSM Nutritional Products,
  • Neo Heliopan E 1000 Isoamyl methoxycinnamate sold under the trade name Neo Heliopan E 1000 by Symrise,
  • Benzophenone-2 sold under the trade name Uvinul D50 by BASF
  • Benzophenone-3 or Oxybenzone sold under the trade name Uvinul M40 by BASF
  • Benzophenone-6 sold under the trade name Helisorb 1 1 by Norquay,
  • Benzophenone-8 sold under the trade name Spectra-Sorb UV-24 by American Cyanamid,
  • n-hexyl 2-(4-diethylamino-2-hydroxybenzoyl)benzoate sold under the trade name Uvinul A+ or in the form of a mixture with octyl methoxycinnamate under the trade name Uvinul A + B by BASF,
  • Phenylbenzimidazolesulfonic acid sold in particular under the trade name Eusolex 232 by Merck,
  • Ethylhexyltriazone sold in particular under the trade name Uvinul T150 by BASF,
  • Neo Heliopan MA Menthyl anthranilate sold under the trade name Neo Heliopan MA by Symrise,
  • Polyorganosiloxane containing benzalmalonate functions for instance Polysilicone-15, sold under the trade name Parsol SLX by Hoffmann LaRoche, 4,4-Diarylbutadiene derivatives:
  • the preferential additional organic screening agents are chosen from:
  • the additional mineral screening agents are chosen from coated or uncoated metal oxide pigments, for instance pigments of titanium oxide (amorphous or crystallized in rutile and/or anatase form), iron oxide, zinc oxide, zirconium oxide or cerium oxide, which are all UV-photoprotective agents that are well known per se.
  • the pigments may be coated or uncoated.
  • the coated pigments are pigments that have undergone one or more surface treatments of chemical, electronic, mechanochemical and/or mechanical nature with compounds as described, for example, in Cosmetics & Toiletries, February 1990, Vol. 105, pp. 53-64, such as amino acids, beeswax, fatty acids, fatty alcohols, anionic surfactants, lecithins, sodium, potassium, zinc, iron or aluminium salts of fatty acids, metal alkoxides (of titanium or of aluminium), polyethylene, silicones, proteins (collagen, elastin), alkanolamines, silicon oxides, metal oxides or sodium hexametaphosphate.
  • surface treatments of chemical, electronic, mechanochemical and/or mechanical nature with compounds as described, for example, in Cosmetics & Toiletries, February 1990, Vol. 105, pp. 53-64 such as amino acids, beeswax, fatty acids, fatty alcohols, anionic surfactants, lecithins, sodium, potassium, zinc, iron
  • silicones are organosilicon polymers or oligomers of linear or cyclic, branched or crosslinked structure, of variable molecular weight, obtained by polymerization and/or polycondensation of suitably functionalized silanes, and consist essentially of a repetition of main units in which the silicon atoms are linked together via oxygen atoms (siloxane bond), optionally substituted hydrocarbon-based radicals being directly attached via a carbon atom to the said silicon atoms.
  • sicones also includes the silanes required for their preparation, in particular alkyl silanes.
  • the silicones used for coating the nanopigments that are suitable for the present invention are preferably chosen from the group containing alkyl silanes, polydialkylsiloxanes and polyalkylhydrogenosiloxanes. Even more preferentially, the silicones are chosen from the group containing octyltrimethylsilane, polydimethylsiloxanes and polymethylhydrogenosiloxanes. Needless to say, before being treated with silicones, the metal oxide pigments may have been treated with other surface agents, in particular with cerium oxide, alumina, silica, aluminium compounds or silicon compounds, or mixtures thereof.
  • coated pigments are, for example, titanium oxides that have been coated: with silica, such as the product Sunveil from the company Ikeda and the product Eusolex T-AVO from the company Merck,
  • silica and iron oxide such as the product Sunveil F from the company Ikeda
  • silica and alumina such as the products Microtitanium Dioxide MT 500 SA and Microtitanium Dioxide MT 100 SA from the company Tayca, Tioveil from the company Tioxide and Mirasun TiW 60 from the company Rhodia,
  • alumina such as the products Tipaque TTO-55 (B) and Tipaque TTO-55 (A) from the company Ishihara and UVT 14/4 from the company Kemira
  • alumina and aluminium stearate such as the product Microtitanium Dioxide MT 100 TV, MT 100 TX, MT 100 Z and MT-01 from the company Tayca
  • silica, alumina and alginic acid such as the product MT-100 AQ from the company Tayca,
  • alumina and aluminium laurate such as the product Microtitanium Dioxide MT 100 S from the company Tayca,
  • iron oxide and iron stearate such as the product Microtitanium Dioxide MT 100 F from the company Tayca,
  • zinc oxide and zinc stearate such as the product BR351 from the company Tayca
  • silica, alumina and aluminium stearate and treated with a silicone such as the product STT-30-DS from the company Titan Kogyo,
  • silica and treated with a silicone such as the product UV-Titan X 195 from the company Kemira, or the product SMT-100 WRS from the company Tayca, with alumina and treated with a silicone, such as the products Tipaque TTO-55 (S) from the company Ishihara or UV Titan M 262 from the company Kemira, with triethanolamine, such as the product STT-65-S from the company Titan Kogyo,
  • titanium oxide pigments treated with a silicone are, for example, T1O2 treated with octyltrimethylsilane, such as the product sold under the trade name T 805 by the company Degussa Silicas, T1O2 treated with a polydimethylsiloxane, such as the product sold under the trade name 70250 Cardre UF TiO2SI3 by the company Cardre, anatase/rutile T1O2 treated with a polydimethylhydrogenosiloxane, such as the product sold under the trade name Microtitanium Dioxide USP Grade Hydrophobic by the company Color Techniques.
  • the uncoated titanium oxide pigments are sold, for example, by the company Tayca under the trade names Microtitanium Dioxide MT 500 B or Microtitanium Dioxide MT 600 B, by the company Degussa under the name P 25, by the company Wacker under the name Transparent titanium oxide PW, by the company Miyoshi Kasei under the name UFTR, by the company Tomen under the name ITS and by the company Tioxide under the name Tioveil AQ.
  • the uncoated zinc oxide pigments are, for example:
  • Nanogard WCD 2025 those sold under the name Nanogard WCD 2025 by the company Nanophase Technologies.
  • coated zinc oxide pigments are, for example:
  • Zinc Oxide CS-5 those sold under the name Zinc Oxide CS-5 by the company Toshibi (ZnO coated with polymethylhydrogenosiloxane);
  • Nanogard Zinc Oxide FN those sold under the name Nanogard Zinc Oxide FN by the company Nanophase Technologies (as a 40% dispersion in Finsolv TN, C12-C15 alkyl benzoate);
  • Daitopersion ZN-30 and Daitopersion ZN-50 by the company Daito (dispersions in cyclopolymethylsiloxane/oxyethylenated polydimethylsiloxane, containing 30% or 50% of nanozinc oxides coated with silica and polymethylhydrogenosiloxane);
  • Nanox Gel TN those sold under the name Nanox Gel TN by the company Elementis (ZnO dispersed at a concentration of 55% in C12-C15 alkyl benzoate with hydroxystearic acid polycondensate).
  • the uncoated cerium oxide pigments are sold, for example, under the name Colloidal Cerium Oxide by the company Rhone-Poulenc.
  • the uncoated iron oxide nanopigments are sold, for example, by the company Arnaud under the names Nanogard WCD 2002 (FE 45B), Nanogard Iron FE 45 BL AQ, Nanogard FE 45R AQ and Nanogard WCD 2006 (FE 45R) or by the company Mitsubishi under the name TY-220,
  • the coated iron oxide pigments are sold, for example, by the company Arnaud under the names Nanogard WCD 2008 (FE 45B FN), Nanogard WCD 2009 (FE 45B 556), Nanogard FE 45 BL 345 and Nanogard FE 45 BL or by the company BASF under the name Transparent Iron Oxide.
  • metal oxides especially of titanium dioxide and of cerium dioxide, including the silica-coated equal-weight mixture of titanium dioxide and of cerium dioxide, sold by the company Ikeda under the name Sunveil A, and also the alumina, silica and silicone-coated mixture of titanium dioxide and of zinc dioxide, such as the product M 261 sold by the company Kemira, or the alumina, silica and glycerol -coated mixture of titanium dioxide
  • the additional UV-screening agents are generally present in the compositions according to the invention in proportions ranging from 0.01 % to 20% by weight relative to the total weight of the composition, and preferably ranging from 0.1 % to 10% by weight relative to the total weight of the composition.
  • compositions in accordance with the present invention may also comprise standard cosmetic adjuvants chosen especially from oils, waxes, organic solvents, ionic or nonionic, hydrophilic or lipophilic thickeners, softeners, humectants, opacifiers, stabilizers, emollients, silicones, antifoams, fragrances, preserving agents, anionic, cationic, nonionic, zwitterionic or amphoteric surfactants, active agents, fillers, polymers, propellants, acidifying or basifying agents or any other ingredient usually used in cosmetics and/or dermatology.
  • standard cosmetic adjuvants chosen especially from oils, waxes, organic solvents, ionic or nonionic, hydrophilic or lipophilic thickeners, softeners, humectants, opacifiers, stabilizers, emollients, silicones, antifoams, fragrances, preserving agents, anionic, cationic, nonionic, zwitterionic or
  • Oils that may be mentioned include mineral oils (paraffin); plant oils (sweet almond oil, macadamia oil, blackcurrant seed oil or jojoba oil); synthetic oils, for instance perhydrosqualene, fatty alcohols, fatty amides (for instance isopropyl lauroyl sarcosinate sold under the name Eldew SL-205 by the company Ajinomoto), fatty acids or fatty esters, for instance the C12-C15 alkyl benzoate sold under the trade name Finsolv TN or Witconol TN by the company Witco, 2- ethylphenyl benzoate, for instance the commercial product sold under the name X-Tend 226® by the company ISP, octyl palmitate, isopropyl lanolate and triglycerides, including capric/caprylic acid triglycerides, and dicaprylyl carbonate sold under the name Cetiol CC by the company Cognis, oxyethy
  • waxy compounds examples include carnauba wax, beeswax, hydrogenated castor oil, polyethylene waxes and polymethylene waxes, for instance the product sold under the name Cirebelle 303 by the company Sasol.
  • organic solvents that may be mentioned are lower alcohols and polyols.
  • These polyols may be chosen from glycols and glycol ethers, for instance ethylene glycol, propylene glycol, butylene glycol, dipropylene glycol or diethylene glycol.
  • Hydrophilic thickeners that may be mentioned include carboxyvinyl polymers, such as Carbopols (Carbomers) and the Pemulens (acrylate/C10-C30-alkyl acrylate copolymer); polyacrylamides, for instance the crosslinked copolymers sold under the names Sepigel 305 (CTFA name: polyacrylamide/C13-14 isoparaffin/Laureth 7) or Simulgel 600 (CTFA name: : acrylamide/sodium acryloyldimethyltaurate copolymer/isohexadecane/polysorbate 80) by the company SEPPIC; 2-acrylamido-2-methylpropanesulfonic acid polymers and copolymers, optionally crosslinked and/or neutralized, for instance poly(2- acrylamido-2-methylpropanesulfonic acid) sold by the company Hoechst under the trade name Hostacerin AMPS (CTFA name: ammonium polyacryloyldimethyl taurate or Simul
  • Lipophilic thickeners that may be mentioned include synthetic polymers, such as the poly(C10-C30 alkyl acrylates) sold under the names Intelimer IPA 13-1 and Intelimer IPA 13-6 by Landec, or modified clays, such as hectorite and its derivatives, for instance the products sold under the name Bentone.
  • compositions according to the invention may be prepared according to the techniques that are well known to those skilled in the art. They may in particular be in the form of a simple or complex emulsion (O/W, W/O, O/W/O or W/O/W) such as a cream, a milk or a cream-gel; in the form of an aqueous gel; in the form of a lotion. They may optionally be packaged as an aerosol and may be in the form of a mousse or a spray.
  • the compositions according to the invention are preferably in the form of an oil- in-water or water-in-oil emulsion.
  • the emulsification processes that may be used are of paddle or impeller, rotor- stator and high-pressure homogenizer (HPH) type.
  • the emulsions generally contain at least one emulsifying surfactant chosen from amphoteric, anionic, cationic and nonionic emulsifying surfactants, which are used alone or as a mixture.
  • the emulsifiers are appropriately chosen according to the emulsion to be obtained (W/O or O/W).
  • emulsifying surfactants that may be used for the preparation of the W/O emulsions
  • examples that may be mentioned include sorbitan, glycerol or sugar alkyl esters or ethers; silicone surfactants, for instance dimethicone copolyols, such as the mixture of cydomethicone and of dimethicone copolyol, sold under the name DC 5225 C by the company Dow Corning, and alkyldimethicone copolyols such as laurylmethicone copolyol sold under the name Dow Corning 5200 Formulation Aid by the company Dow Corning; cetyl-dimethicone copolyol, such as the product sold under the name Abil EM 90R by the company Goldschmidt, and the mixture of cetyldimethicone copolyol, of polyglyceryl isostearate (4 mol) and of hexyl laurate, sold under the name Abil WE 09 by the company
  • Polyol alkyl esters that may especially be mentioned include polyethylene glycol esters, for instance PEG-30 dipolyhydroxystearate, such as the product sold under the name Arlacel P135 by the company ICI.
  • Glycerol and/or sorbitan esters that may especially be mentioned include, for example, polyglyceryl isostearate, such as the product sold under the name Isolan Gl 34 by the company Goldschmidt, sorbitan isostearate, such as the product sold under the name Arlacel 987 by the company ICI, sorbitan glyceryl isostearate, such as the product sold under the name Arlacel 986 by the company ICI, and mixtures thereof.
  • emulsifiers examples include nonionic emulsifiers such as oxyalkylenated (more particularly polyoxyethylenated) fatty acid esters of glycerol; oxyalkylenated fatty acid esters of sorbitan; oxyalkyl-enated (oxyethylenated and/or oxypropylenated) fatty acid esters, for instance the mixture PEG-100 stearate/glyceryl stearate sold, for example, by the company ICI under the name Arlacel 165; oxyalkylenated (oxyethylenated and/or oxypropylenated) fatty alkyl ethers; sugar esters, for instance sucrose stearate; fatty alkyl ethers of sugars, especially polyalkylglucosides (APG) such as decylglucoside and laurylglucoside sold, for example, by the company He
  • APG polyalkylglucosides
  • the mixture of the alkyl polyglucoside as defined above with the corresponding fatty alcohol can be in the form of a self-emulsifying composition, for example as disclosed in the document WO-A-92/06778.
  • the aqueous phase of this emulsion may comprise a nonionic vesicular dispersion prepared according to known processes (Bangham, Standish and Watkins, J. Mol. Biol. 13, 238 (1965), FR 2 315 991 and FR 2 416 008).
  • compositions according to the invention find their application in a large number of treatments, especially cosmetic treatments, of the skin, the lips and the hair, including the scalp, especially for protecting and/or caring for the skin, the lips and/or the hair, and/or for making up the skin and/or the lips.
  • compositions according to the invention as defined above for the manufacture of cosmetic products for treating the skin, the lips, the nails, the hair, the eyelashes, the eyebrows and/or the scalp, especially care products, antisun products and makeup products.
  • the cosmetic compositions according to the invention may be used, for example, as makeup products.
  • the cosmetic compositions according to the invention may be used, for example, as care products and/or antisun protection products for the face and/or the body, of liquid to semi-liquid consistency, such as milks, more or less rich creams, cream-gels and pastes. They may optionally be packaged as an aerosol and may be in the form of a mousse or a spray.
  • compositions according to the invention in the form of vaporizable fluid lotions in accordance with the invention are applied to the skin or the hair in the form of fine particles by means of pressurization devices.
  • the devices in accordance with the invention are well known to those skilled in the art and comprise non-aerosol pumps or "atomizers", aerosol containers comprising a propellant and also aerosol pumps using compressed air as propellant. These devices are described in patents US 4 077 441 and US 4 850 517 (which form an integral part of the content of the description).
  • compositions conditioned in aerosol form in accordance with the invention generally contain conventional propellants, for instance hydrofluoro compounds, dichlorodifluoromethane, difluoroethane, dimethyl ether, isobutane, n-butane, propane or trichlorofluoromethane. They are preferably present in amounts ranging from 15% to 50% by weight relative to the total weight of the composition.
  • compositions according to the invention may also comprise additional cosmetic or dermatological active agents. Mention may be made, among active agents, of:
  • moisturizers for instance polyols such as glycerol, butylene glycol or propylene glycol;
  • a person skilled in the art will select the said active agent(s) as a function of the effect desired on the skin, the hair, the eyelashes, the eyebrows and the nails.
  • composition may also comprise at least one ingredient such as fillers with a soft-focus effect or agents for promoting the natural coloration of the skin, intended for complementing the biological effects of these active agents or for providing an immediate visual anti-ageing effect.
  • ingredient such as fillers with a soft-focus effect or agents for promoting the natural coloration of the skin, intended for complementing the biological effects of these active agents or for providing an immediate visual anti-ageing effect.
  • the composition may also comprise at least one additional ingredient intended to provide an immediate visual effect.
  • Mention may be made especially of agents that promotes the naturally pinkish coloration of the skin.
  • agents that promote the naturally pinkish coloration of the skin examples that may be mentioned include self-tanning agents, for instance an agent which, when applied to the skin, especially to the face, makes it possible to obtain a tanning effect more or less similar in appearance to that which may result from prolonged exposure to sunlight (natural tanning) or under a UV lamp.
  • self-tanning agents for instance an agent which, when applied to the skin, especially to the face, makes it possible to obtain a tanning effect more or less similar in appearance to that which may result from prolonged exposure to sunlight (natural tanning) or under a UV lamp.
  • self-tanning agents examples of self-tanning agents that may especially be mentioned include:
  • DHA dihydroxyacetone
  • alkali metal and/or alkaline-earth metal hydrogen carbonates are examples of alkali metal and/or alkaline-earth metal hydrogen carbonates.
  • the self-tanning agents are generally chosen from monocarbonyl or polycarbonyl compounds, for instance isatin, alloxan, ninhydrin, glyceraldehyde, mesotartaric aldehyde, glutaraldehyde, erythrulose, pyrazoline-4,5-dione derivatives as described in patent application FR 2 466 492 and WO 97/35842, dihydroxyacetone (DHA) and 4,4-dihydroxypyrazolin-5-one derivatives as described in patent application EP 903 342.
  • DHA will preferably be used.
  • the DHA may be used in free and/or encapsulated form, for example in lipid vesicles such as liposomes, especially described in patent application WO 97/25970.
  • the self-tanning agent is present in an amount ranging from 0.01 % to 20% by weight and preferably in an amount of between 0.1 % and 10% of the total weight of the composition.
  • These dyes may be chosen from synthetic or natural direct dyes.
  • dyes may be chosen, for example, from red or orange dyes of the fluorane type such as those described in patent application FR 2 840 806. Mention may be made, for example, of the following dyes:
  • dyes may also be chosen from anthraquinones, caramel, carmine, carbon black, azulene blues, methoxalene, trioxalene, guajazulene, chamuzulene, rose Bengal, eosin 10B, cyanosin and daphinin.
  • dyes may also be chosen from indole derivatives, for instance the monohydroxyindoles as described in patent FR 2 651 126 (i.e.: 4-, 5-, 6- or 7- hydroxyindole) or the dihydroxyindoles as described in patent EP-B-0 425 324 (i.e.: 5,6-dihydroxyindole, 2-methyl-5,6-dihydroxyindole, 3-methyl-5,6- dihydroxyindole or 2,3-dimethyl-5,6-dihydroxyindole).
  • indole derivatives for instance the monohydroxyindoles as described in patent FR 2 651 126 (i.e.: 4-, 5-, 6- or 7- hydroxyindole) or the dihydroxyindoles as described in patent EP-B-0 425 324 (i.e.: 5,6-dihydroxyindole, 2-methyl-5,6-dihydroxyindole, 3-methyl-5,6- dihydroxyindole or 2,3
  • 3-Anilinoacrolein aniline (2 g, 9x10 "3 mol) and methylmethanesulfonyl acetate (1 .37 ml, 9x10 "3 mol) are heated at 105°C in 5 ml of acetic anhydride for 2 hours 30 minutes. After cooling, the acetic anhydride is evaporated off under vacuum. The brown solid obtained is taken up in 40 ml of methanol and brought to reflux. After cooling, the solid obtained is filtered off, rinsed with cold methanol and dried.
  • Thionyl chloride (15 ml) is reacted, with stirring, with cyanoacetic acid (2 g, 0.024 mol) and maintained at 40°C for 2 hours. 50 ml of toluene are added and the mixture is concentrated under vacuum until a residual volume of 10 ml is obtained. The sodium salt of isethionic acid (3.48 g, 0.024 mol) is added thereto and the mixture is maintained at the reflux point of the toluene. The heterogeneous mixture is refluxed for 20 hours. After cooling, the reaction mixture is filtered. The solid is taken up in water and the aqueous phase is washed with ethyl acetate. The aqueous phase is brought to neutral pH with 2N sodium hydroxide.
  • compositions A and B were prepared:

Abstract

The present invention relates to a cosmetic composition containing a combination i) of at least one screening agent of the dibenzoylmethane derivative type and ii) of at least one particular hydrophilic or water-soluble merocyanin UV-screening agent, especially corresponding to one of the formulae (I) or (II) below: in which at least one or two of the radicals contain: - either an alkylsulfonate radical in its acid or salified form - or one or two hydroxy I radicals. The invention also relates to a process for the radiation-photostabilization of at least one screening agent of the dibenzoylmethane derivative type with an effective amount of at least one particular hydrophilic or water-soluble merocyanin UV-screening agent, especially corresponding to one of the formulae (I) or (II).

Description

COMPOSITION CONTAINING A DIBENZOYLMETHANE SCREENING AGENT AND A HYDROPHILIC OR WATER-SOLUBLE MEROCYANIN UV- SCREENING AGENT; PROCESS FOR PHOTOSTABILIZING THE DIBENZOYLMETHANE SCREENING AGENT
The present invention relates to a cosmetic composition containing a combination i) of at least one screening agent of the dibenzoylmethane derivative type and ii) of at least one particular hydrophilic or water-soluble merocyanin UV-screening agent, the definition of which will be given below.
The invention also relates to a process for the radiation-photostabilization of at least one screening agent of the dibenzoylmethane derivative type with an effective amount of at least one particular hydrophilic or water-soluble merocyanin UV-screening agent, the definition of which will be given below.
It is known that light radiation with wavelengths of between 280 nm and 400 nm permits tanning of the human epidermis and that light rays with wavelengths more particularly between 280 and 320 nm, known as UV-B rays, cause skin burns and erythema which can harm the development of a natural tan. For these reasons, and also for aesthetic reasons, there is constant demand for means for controlling this natural tanning in order thus to control the colour of the skin; this UV-B radiation should thus be screened out.
It is also known that UV-A rays, with wavelengths between 320 and 400 nm, which cause tanning of the skin, are liable to induce adverse changes therein, in particular in the case of sensitive skin or skin that is continually exposed to solar radiation. UV-A rays cause in particular a loss of elasticity of the skin and the appearance of wrinkles leading to premature ageing of the skin. They promote triggering of the erythemal reaction or amplify this reaction in certain individuals and may even be the cause of phototoxic or photoallergic reactions. Thus, for aesthetic and cosmetic reasons, for instance conservation of the skin's natural elasticity, people increasingly wish to control the effect of UV-A rays on their skin. It is thus desirable also to screen out UV-A radiation. For the purpose of protecting the skin and keratin materials against UV radiation, antisun compositions comprising organic screening agents that are active in the UV-A range and in the UV-B range are generally used. The majority of these screening agents are liposoluble. In this respect, one particularly advantageous family of UV-A screening agents currently consists of dibenzoylmethane derivatives, and in particular 4-tert-butyl- 4'-methoxydibenzoylmethane, which have high intrinsic absorbing power. These dibenzoylmethane derivatives, which are products that are now well known per se as screening agents that are active in the UV-A range, are described in particular in French patent applications FR-A-2 326 405 and FR-A-2 440 933, and also in European patent application EP-A-0 1 14 607; 4-tert-butyl-4'- methoxy-dibenzoylmethane is moreover currently sold under the trade name Parsol 1789® by the company DSM Nutritional Products. Unfortunately, it has been found that dibenzoyl-methane derivatives are products that are relatively sensitive to ultraviolet radiation (especially UV-A), i.e., more specifically, they have an annoying tendency to be degraded more or less quickly under the action of this radiation. Thus, this substantial lack of photochemical stability of dibenzoylmethane derivatives towards ultraviolet radiation, to which they are by nature intended to be subjected, does not make it possible to ensure constant protection during prolonged exposure to the sun, and so the user must make repeated applications at regular and close time intervals in order to obtain effective protection of the skin against UV rays.
Patent application WO 01/28732 discloses a process for photostabilizing a dibenzoylmethane derivative with a merocyanin phenyl sulfone derivative. Firstly, this photostabilization of the dibenzoylmethane derivative with the merocyanin phenyl sulfone derivative is not entirely satisfactory. Secondly, these merocyanin phenyl sulfone derivatives have the drawback of being degraded in the presence of dibenzoylmethane under the influence of UV radiation.
Patent application WO 2008/090 066 has already proposed photostabilizing dibenzoylmethane derivatives with cyclic merocyanin cyanoacetate derivatives. In this case also, the photostabilization of the dibenzoylmethane derivative remains insufficient and these merocyanin cyanoacetate derivatives also have the drawback of being degraded in the presence of dibenzoylmethane. The photostabilization of dibenzoylmethane derivatives towards UV radiation thus constitutes, at the present time, a problem that has still not been solved entirely satisfactorily.
The Applicant has now discovered, surprisingly, that by combining the dibenzoylmethane derivatives mentioned above with a particular hydrophilic or water-soluble merocyanin UV-screening agent, the definition of which will be given later, which are active in the UV-A range, it is possible firstly to substantially improve the photochemical stability (or photostability) of the dibenzoylmethane derivatives and, secondly, to extend the filtration of the composition in the longer UV-A range while at the same time giving cosmetically acceptable coloration.
This discovery forms the basis of the present invention. Thus, in accordance with one of the subjects of the present invention, a composition is now proposed comprising, in a cosmetically acceptable support, at least one UV-screening system, characterized in that it comprises:
(i) at least one dibenzoylmethane derivative and
(ii) at least one particular hydrophilic or water-soluble merocyanin UV- screening agent, the definition of which will be given below.
Another subject of the invention also concerns a process for improving the chemical stability towards UV radiation of at least one dibenzoylmethane derivative, which consists in combining the said dibenzoylmethane derivative with an effective amount of at least one particular hydrophilic or water-soluble merocyanin UV-screening agent, the definition of which will be given below.
Other characteristics, aspects and advantages of the invention will emerge on reading the detailed description that follows.
The term "cosmetically acceptable" means compatible with the skin and/or its integuments, which has a pleasant colour, odour and feel, and which does not cause any unacceptable discomfort (stinging, tautness or redness) liable to dissuade the consumer from using this composition.
In the rest of the present description, the term "hydrophilic UV-screening agent" means any agent for screening out UV radiation, which may be soluble in an aqueous phase at 1 -5% by weight (transparent) or water-dispersible in the form of a suspension of particles smaller than 100 microns.
Also, the term "water-soluble screening agent" means any agent for screening out UV radiation, which may be soluble in its cosmetically acceptable salt form in an aqueous phase at more than 5% by weight.
The term "effective amount" means an amount that is sufficient to obtain a notable and significant improvement in the photostability of the dibenzoylmethane derivative(s) in the cosmetic composition. This minimum amount of merocyanin derivatives according to the invention, which may vary according to the nature of the support adopted for the composition, may be determined without any difficulty by means of a standard test for measuring photostability, such as the test given in the examples hereinbelow.
Among the dibenzoylmethane derivatives that may especially be mentioned, in a non-limiting manner, are:
- 2-methyldibenzoylmethane,
- 4-methyldibenzoylmethane,
- 4-isopropyldibenzoylmethane,
- 4-tert-butyldibenzoylmethane,
- 2,4-dimethyldibenzoylmethane,
- 2,5-dimethyldibenzoylmethane,
- 4,4'-diisopropyldibenzoylmethane,
- 4,4'-dimethoxydibenzoylmethane,
- 4-tert-butyl-4'-methoxydibenzoylmethane,
- 2-methyl-5-isopropyl-4'-methoxydibenzoylmethane,
- 2-methyl-5-tert-butyl-4'-methxydibenzoylmethane,
- 2,4-dimethyl-4'-methoxydibenzoylmethane,
- 2,6-dimethyl-4-tert-butyl-4'-methoxydibenzoylmethane. Among the dibenzoylmethane derivatives mentioned above, 4- isopropyldibenzoylmethane will be used in particular, which is sold under the name Eusolex 8020 by the company Merck, and corresponds to the following formula:
Figure imgf000005_0001
It is most particularly preferred to use 4-(tert-butyl)-4'-methoxydibenzoylmethane or Butyl Methoxy Dibenzoylmethane or Avobenzone, sold under the trade name Parsol 1789 by the company DSM Nutritional Products, Inc.; this screening agent corresponds to the following formula:
Figure imgf000005_0002
The dibenzoylmethane derivative(s) may be present in the compositions in accordance with the invention in contents preferably ranging from 0.01 % to 20% by weight, more preferentially from 0.1 % to 10% by weight and even more preferentially from 0.1 % to 6% by weight relative to the total weight of the composition.
The hydrophilic or water-soluble merocyanin compounds in accordance with the invention are chosen from the group formed by:
(1 ) those corresponding to one of the formulae (I) and (II) below, and the salts thereof:
Figure imgf000005_0003
in which:
- Ri and R2, which may be identical or different, represent H; a linear or branched C1-C22 alkyl radical possibly containing from 1 to 3 oxygen atoms; a C3-C8 cycloalkyl radical, which is unsubstituted or substituted with Ci-C4 alkyl radicals; the said radicals Ri and R2 possibly containing an alkylsulfonate radical in its acid or salified form or one or two hydroxyl radicals;
- Ri and R2 may form, together with the nitrogen, a ring containing the group - (CH2)m-, which is uninterrupted or interrupted with one or more -O-, -S- or -NH-, - Ri may form, with the carbon alpha to the nitrogen, a ring containing the group -(CH2)m-, which is uninterrupted or interrupted with one or more -O-, -S- or -NH-,
- R3 represents a carboxyl, -COOR5, -CONHR5, -COR5, -CONR5R1 , SO2R5, or - CN group,
- R4 represents a carboxyl, -COOR6, -CONHR6, -COR6, -CONR6R2 or SO2R6 group,
- R5 and R6, which may be identical or different, represent a linear or branched Ci-C22 alkyl radical possibly containing from 1 to 3 oxygen atoms; a C3-C8 cycloalkyi radical, which is unsubstituted or substituted with Ci-C4 alkyl radicals; the said radicals R5 and R6 possibly containing an alkylsulfonate radical in its acid or salified form or one or two hydroxyl radicals,
- Z represents the group -(CH2)i- , which is uninterrupted or interrupted with -O-, -S- or -NR7-, and/or unsubstituted or substituted with one or two C1-C6 alkyl radicals,
- R7 is a C1-C5 alkyl radical possibly containing an alkylsulfonate radical in its acid or salified form or one or two hydroxyl radicals,
- n is 1 -2; - m is 1 -7; - 1 is 1 -4;
with at least one or two of the radicals Ri , R2, R5, R6 and R7 containing
- either an alkylsulfonate radical in its acid or salified form
- or one or two hydroxyl radicals;
with the proviso that:
(1) when n = 2, one of the radicals Ri , R5 or R6 is an alkyl diradical or Ri and R2 together with two nitrogen atoms form a cyclic divalent radical -(CH2)m-;
(ii) Ri and R2 are not simultaneously a hydrogen atom;
(iii) when R3 is -CN, then at least one of the radicals Ri , R2 or R6 must contain an alkylsulfonate group in its acid or salified form;
(2) the merocyanin compounds chosen from the group formed by the following molecules, and also salts thereof and the Ε,Ε-, Ε,Ζ- or Ζ,Ζ- geometrical isomer forms thereof
Figure imgf000006_0001
Figure imgf000006_0002
Figure imgf000007_0001
Figure imgf000008_0001
Figure imgf000009_0001
Figure imgf000010_0001
10
Figure imgf000011_0001
(bn) (bo)
Figure imgf000011_0002
The merocyanin compounds of the invention may be in the Ε,Ε-, Ε,Ζ- or Ζ,Ζ- geometrical isomer forms.
The term "diradical" means a divalent radical such that the two units
Figure imgf000011_0003
are linked together via this diradical.
Illustrations that may be mentioned include compounds (u) and (ar) below:
Figure imgf000011_0004
Figure imgf000011_0005
(ar)
In the case where n = 2, for instance a cyclic divalent radical -(CH2)m- formed by Ri and R2 with the two nitrogen atoms, mention may be made of the compound (ax)
Figure imgf000012_0001
(ax)
Examples of linear or branched alkyl radicals that may be mentioned include: methyl, ethyl, n-propyl, isopropyl, 1 -methylethyl, butyl, pentyl, hexyl, 2- ethyl hexyl, octyl, 1 -methylheptyl.
C3-C8 cycloalkyl radicals that may be mentioned include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, 1 -methylcyclopropyl, 1 -ethylcyclopropyl, 1 -propylcyclopropyl, 1 -butylcyclopropyl, 1 -methyl-1 -butylcyclopropyl, 1 ,2-dimethylcyclypropyl, 1 -methyl-2-ethylcyclopropyl and cyclooctyl.
The acceptable salts of the merocyanin compounds described in the present invention comprise conventional non-toxic salts of the said compounds, such as those formed from organic or mineral bases, such as amine salts, for instance salts of alkanolamines such as triethanolamine, amino acid salts or aminopropanediol salts, and salts of an alkali metal or alkaline-earth metal, for instance sodium or potassium.
The preferred salts are salts of an alkali metal such as sodium or potassium, or salts of an amine such as triethanolamine.
The preferred compounds of formula (I) are those for which the following conditions are satisfied:
Ri denotes hydrogen; a linear or branched Ci-Cs alkyl radical possibly containing from 1 to 3 oxygen atoms,
R2 denotes a linear or branched Ci-Cs alkyl radical possibly containing from 1 to
3 oxygen atoms or a C5-C6 cycloalkyl radical,
R3 denotes a group -COOR5, -CN or -CONHR5,
R4 denotes a group -COOR6, -CONHR6 or -SO2R6,
R5 denotes a linear or branched C1-C12 alkyl radical possibly containing from 1 to 3 oxygen atoms,
n is equal to 1 or 2;
with at least one or two of the radicals Ri , R2, R5, R6 containing
- either an alkylsulfonate radical in its acid or salified form
- or one or two hydroxyl radicals.
The compounds of formula (I) with one or two alkylsulfonate radicals that are even more particularly preferred are chosen from those having the following formulae: 
Figure imgf000013_0001
Figure imgf000014_0001
Figure imgf000014_0002
The compounds of formula (I) containing hydroxyl groups that are particularly preferred are those having the following formulae:
Figure imgf000015_0001
The preferred compounds of formula (II) are those for which the following conditions are satisfied:
Ri denotes hydrogen; a linear or branched C1-C10 alkyl radical possibly containing from 1 to 3 oxygen atoms,
R2 denotes a linear or branched C1-C10 alkyl radical possibly containing from 1 to 3 oxygen atoms; a C5-C6 cycloalkyl,
R3 denotes a group -COOR5 or CN,
R4 denotes a group -COOR6 or -SO2R6,
R5 denotes a linear or branched C1-C12 alkyl radical possibly containing from 1 to 3 oxygen atoms,
Z is -(CH2)3- which may or may not be substituted with two groups CH3, n is equal to 1 or 2;
with at least one or two of the radicals Ri , R2, R5, R6 containing
- either an alkylsulfonate radical in its acid or salified form
- or one or two hydroxyl radicals.
The compounds of formula (II) that are particularly preferred are those having the following formulae:
Figure imgf000016_0001
Among the merocyanin compounds in accordance with the invention that are particularly preferred, the following compounds will be chosen more particularly:
Figure imgf000016_0002
Figure imgf000016_0003
Figure imgf000016_0004
Figure imgf000017_0001
(bn) (bo)
Figure imgf000018_0001
(bp)
The linear merocyanin derivatives in accordance with the invention, in particular those of formula (I), may be prepared according to a method described in patents US 4 045 229, US 4 195 999 and US 2009/0 170 008 according to the following scheme (route 1 ):
Figure imgf000018_0002
(V) (VI) or according to a method described in patent WO 00/07989, and according to the following scheme (route 2):
Route 2
Toluene
(-H20)
(I)
I
R2 cat.: Amine, AcOH
(VII) (IV)
in which the radicals Ri , R2, R3 and R4 have the meaning of formula (I).
The cyclic merocyanin derivatives in accordance with the invention, in particular those of formula (II), may be prepared according to a method described in IP.COM Journal 9(5A), 29-30 (2009) according to the following scheme:
in which the radicals Ri , R2, R3, R4 and Z have the meaning of formula (II).
Some of the hydrophilic or water-soluble merocyanin compounds in accordance with the invention are novel and constitute another subject of the invention.
Among the compounds of formula (I) with one or two alkylsulfonate radicals, the following compounds are novel:
Figure imgf000019_0001

Figure imgf000020_0001
Figure imgf000021_0001
Figure imgf000021_0002
Figure imgf000021_0003
is The compounds of formula (II) are novel, in particular the following compounds: 21
Figure imgf000022_0001
22
Figure imgf000023_0001
Figure imgf000024_0001

Figure imgf000025_0001
Figure imgf000026_0001
Figure imgf000026_0002
Figure imgf000026_0003
The hydrophilic or water-soluble merocyanin screening agent(s) in accordance with the invention may be present in the compositions according to the invention in a concentration of between 0.1 % and 10% and preferably between 0.2% and 5% by weight relative to the total weight of the composition.
The compositions in accordance with the invention may also comprise other additional UVA-active and/or UVB-active organic or mineral UV-screening agents that are water-soluble or liposoluble or even insoluble in the cosmetic solvents commonly used.
Needless to say, a person skilled in the art will take care to select the optional additional screening agent(s) and/or the amounts thereof such that the advantageous properties intrinsically associated with the compositions in accordance with the invention are not, or are not substantially, adversely affected by the envisaged addition(s), especially the improvement in the photostability of the dibenzoylmethane derivative.
The additional organic screening agents are chosen especially from anthranilates; cinnamic derivatives; salicylic derivatives; camphor derivatives; benzophenone derivatives; , diphenylacrylate derivatives; triazine derivatives other than those of formula (II); benzotriazole derivatives; benzalmalonate derivatives, especially those mentioned in patent US 5 624 663; benzimidazole derivatives; imidazolines; bis-benzazolyl derivatives as described in patents EP 669 323 and US 2 463 264; p-aminobenzoic acid (PABA) derivatives; methylenebis(hydroxyphenylbenzotriazole) derivatives as described in patent applications US 5 237 071 , US 5 166 355, GB 2 303 549, DE 197 26 184 and EP 893 1 19; benzoxazole derivatives as described in patent applications EP 0 832 642, EP 1 027 883, EP 1 300 137 and DE 101 62 844; screening polymers and screening silicones such as those described especially in patent application WO 93/04665; aalkylstyrene-based dimers, such as those described in patent application DE 198 55 649; 4,4-diarylbutadienes such as those described in patent applications EP 0 967 200, DE 197 46 654, DE 197 55 649, EP-A-1 008 586, EP 1 133 980 and EP 133 981 ; merocyanin derivatives other than those of formula (I), such as those described in patent applications WO 04/006 878, WO 05/058 269 and WO 06/032 741 ; and mixtures thereof.
As examples of organic UV-screening agents, mention may be made of those denoted hereinbelow under their INCI name: para-aminobenzoic acid derivatives:
PABA,
Ethyl PABA,
Ethyl Dihydroxypropyl PABA,
Ethylhexyl dimethyl PABA sold in particular under the name Escalol 507 by ISP, Glyceryl PABA,
PEG-25 PABA sold under the name Uvinul P25 by BASF, Salicylic derivatives:
Homosalate sold under the name Eusolex HMS by Rona/EM Industries,
Ethylhexyl salicylate sold under the name Neo Heliopan OS by Symrise,
Dipropylene glycol salicylate sold under the name Dipsal by Scher,
TEA salicylate sold under the name Neo Heliopan TS by Symrise,
Cinnamic derivatives:
Ethylhexyl methoxycinnamate sold especially under the trade name Parsol MCX by DSM Nutritional Products,
Isopropyl methoxycinnamate,
Isoamyl methoxycinnamate sold under the trade name Neo Heliopan E 1000 by Symrise,
Cinoxate,
DEA Methoxycinnamate,
Diisopropyl methylcinnamate,
Glyceryl ethylhexanoate dimethoxycinnamate, β,β-Diphenylacrylate derivatives:
Octocrylene sold especially under the trade name Uvinul N539 by BASF, Etocrylene sold especially under the trade name Uvinul N35 by BASF,
Benzophenone derivatives:
Benzophenone-1 sold under the trade name Uvinul 400 by BASF,
Benzophenone-2 sold under the trade name Uvinul D50 by BASF, Benzophenone-3 or Oxybenzone sold under the trade name Uvinul M40 by BASF,
Benzophenone-4 sold under the trade name Uvinul MS40 by BASF,
Benzophenone-5,
Benzophenone-6 sold under the trade name Helisorb 1 1 by Norquay,
Benzophenone-8 sold under the trade name Spectra-Sorb UV-24 by American Cyanamid,
Benzophenone-9 sold under the trade name Uvinul DS-49 by BASF,
Benzophenone-12,
n-hexyl 2-(4-diethylamino-2-hydroxybenzoyl)benzoate sold under the trade name Uvinul A+ or in the form of a mixture with octyl methoxycinnamate under the trade name Uvinul A + B by BASF,
1 ,1 '-(1 ,4-piperazinediyl)bis[1 -[2-[4-(diethylamino)-2- hydroxybenzoyl]phenyl]methanone (CAS 919803-06-8),
Benzyl idenecamphor derivatives:
3- Benzylidenecamphor manufactured under the name Mexoryl SD by Chimex,
4- Methylbenzylidenecamphor sold under the name Eusolex 6300 by Merck, Benzylidenecamphorsulfonic acid manufactured under the name Mexoryl SL by Chimex,
Camphor benzalkonium methosulfate manufactured under the name Mexoryl SO by Chimex,
Terephthalylidenedicamphorsulfonic acid manufactured under the name Mexoryl SX by Chimex,
Polyacrylamidomethylbenzylidenecamphor manufactured under the name Mexoryl SW by Chimex,
Phenylbenzimidazole derivatives:
Phenylbenzimidazolesulfonic acid sold in particular under the trade name Eusolex 232 by Merck,
Disodium phenyl dibenzimidazole tetrasulfonate sold under the trade name Neo Heliopan AP by Symrise,
Phenylbenzotriazole derivatives:
Drometrizole trisiloxane sold under the name Silatrizole by Rhodia Chimie, Methylenebis(benzotriazolyl)tetramethylbutylphenol sold in solid form under the trade name Mixxim BB/100 by Fairmount Chemical, or in micronized form as an aqueous dispersion under the trade name Tinosorb M by Ciba Specialty Chemicals,
T azine derivatives:
Bis(ethylhexyloxyphenol)methoxyphenyltriazine sold under the trade name Tinosorb S by Ciba Geigy,
Ethylhexyltriazone sold in particular under the trade name Uvinul T150 by BASF,
Diethylhexylbutamidotriazone sold under the trade name Uvasorb HEB by Sigma 3V,
2,4,6-Tris(diisobutyl 4'-aminobenzalmalonate)-s-triazine,
2,4,6-Tris(dineopentyl 4'-aminobenzalmalonate)-s-triazine, 2,4-Bis(dineopentyl 4'-aminobenzalmalonate)-6-(n-butyl 4'-aminobenzoate)-s- triazine,
2,4-Bis(n-butyl 4'-aminobenzoate)-6-[(3-{1 ,3,3,3-tetramethyl-l -
[(trimethylsilyl)oxy]-disiloxanylpropyl)amino]-s-tnazine,
the symmetrical triazine screening agents described in patent US 6 225 467, patent application WO 2004/085 412 (see compounds 6 and 9) or the document Symmetrical Triazine Derivatives IP.COM Journal, IP.COM INC West Henrietta, NY, US (20 September 2004), especially 2,4,6-tris(biphenyl)-1 ,3,5-triazines (in particular 2,4,6-tris(biphenyl-4-yl-1 ,3,5-triazine) and 2,4,6-tris(terphenyl)-1 ,3,5- triazine which is also mentioned in Beiersdorf patent applications WO 06/035 000, WO 06/034 982, WO 06/034 991 , WO 06/035 007, WO 2006/034 992 and WO 2006/034 985,
Anthranilic derivatives:
Menthyl anthranilate sold under the trade name Neo Heliopan MA by Symrise,
Imidazoline derivatives:
Ethylhexyldimethoxybenzylidenedioxoimidazoline propionate, Benzalmalonate derivatives:
Dineopentyl 4'-methoxybenzalmalonate
Polyorganosiloxane containing benzalmalonate functions, for instance Polysilicone-15, sold under the trade name Parsol SLX by Hoffmann LaRoche, 4,4-Diarylbutadiene derivatives:
1 ,1 -Dicarboxy(2,2'-dimethylpropyl)-4,4-diphenyl-butadiene,
Benzoxazole derivatives:
2,4-bis[5-1 (dimethylpropyl)benzoxazol-2-yl-(4-phenyl)imino]-6-(2- ethylhexyl)imino-1 ,3,5-triazine, sold under the name of Uvasorb K2A by Sigma 3V,
and mixtures thereof.
The preferential additional organic screening agents are chosen from:
Ethylhexyl methoxycinnamate,
Homosalate,
Ethylhexyl salicylate,
Octocrylene,
Phenylbenzimidazolesulfonic acid,
Benzophenone-3,
Benzophenone-4,
Benzophenone-5,
n-Hexyl 2-(4-diethylamino-2-hydroxybenzoyl)-benzoate,
1 ,1 '-(1 ,4-Piperazinediyl)bis[1 -[2-[4-(diethylamino)-2- hydroxybenzoyl]phenyl]methanone,
4-Methylbenzylidenecamphor,
Terephthalylidenedicamphorsulfonic acid,
Disodium phenyldibenzimidazoletetrasulfonate,
Ethylhexyl triazone,
Bis(ethylhexyloxyphenol)methoxyphenyltriazine, Diethylhexylbutamidotriazone,
2,4,6-Tris(biphenyl-4-yl)-1 ,3,5-triazine,
2,4,6-Tris(dineopentyl 4'-aminobenzalmalonate)-s-triazine,
2,4,6-Tris(diisobutyl 4'-aminobenzalmalonate)-s-triazine,
2,4-Bis(dineopentyl 4'-aminobenzalnnalonate)-6-(n-butyl 4'-aminobenzoate)-s- triazine,
2,4-Bis(n-butyl 4'-aminobenzoate)-6-[(3-{1 ,3,3,3-tetramethyl-1 -
[(trimethylsilyl)oxy]-disiloxanylpropyl)amino]-s-triazine,
Methylenebis(benzotriazolyl)tetramethylbutylphenol,
Drometrizole trisiloxane,
Polysilicone-15,
Dineopentyl 4'-methoxybenzalnnalonate
1 ,1 -Dicarboxy(2,2'-dimethylpropyl)-4,4-diphenyl-butadiene,
2,4-Bis[5-1 (dimethylpropyl)benzoxazol-2-yl-(4-phenyl)imino]-6-(2- ethylhexyl)imino-1 ,3,5-triazine,
and mixtures thereof.
The additional mineral screening agents are chosen from coated or uncoated metal oxide pigments, for instance pigments of titanium oxide (amorphous or crystallized in rutile and/or anatase form), iron oxide, zinc oxide, zirconium oxide or cerium oxide, which are all UV-photoprotective agents that are well known per se.
The pigments may be coated or uncoated.
The coated pigments are pigments that have undergone one or more surface treatments of chemical, electronic, mechanochemical and/or mechanical nature with compounds as described, for example, in Cosmetics & Toiletries, February 1990, Vol. 105, pp. 53-64, such as amino acids, beeswax, fatty acids, fatty alcohols, anionic surfactants, lecithins, sodium, potassium, zinc, iron or aluminium salts of fatty acids, metal alkoxides (of titanium or of aluminium), polyethylene, silicones, proteins (collagen, elastin), alkanolamines, silicon oxides, metal oxides or sodium hexametaphosphate. As is known, silicones are organosilicon polymers or oligomers of linear or cyclic, branched or crosslinked structure, of variable molecular weight, obtained by polymerization and/or polycondensation of suitably functionalized silanes, and consist essentially of a repetition of main units in which the silicon atoms are linked together via oxygen atoms (siloxane bond), optionally substituted hydrocarbon-based radicals being directly attached via a carbon atom to the said silicon atoms.
The term "silicones" also includes the silanes required for their preparation, in particular alkyl silanes.
The silicones used for coating the nanopigments that are suitable for the present invention are preferably chosen from the group containing alkyl silanes, polydialkylsiloxanes and polyalkylhydrogenosiloxanes. Even more preferentially, the silicones are chosen from the group containing octyltrimethylsilane, polydimethylsiloxanes and polymethylhydrogenosiloxanes. Needless to say, before being treated with silicones, the metal oxide pigments may have been treated with other surface agents, in particular with cerium oxide, alumina, silica, aluminium compounds or silicon compounds, or mixtures thereof.
The coated pigments are, for example, titanium oxides that have been coated: with silica, such as the product Sunveil from the company Ikeda and the product Eusolex T-AVO from the company Merck,
with silica and iron oxide, such as the product Sunveil F from the company Ikeda,
with silica and alumina, such as the products Microtitanium Dioxide MT 500 SA and Microtitanium Dioxide MT 100 SA from the company Tayca, Tioveil from the company Tioxide and Mirasun TiW 60 from the company Rhodia,
with alumina, such as the products Tipaque TTO-55 (B) and Tipaque TTO-55 (A) from the company Ishihara and UVT 14/4 from the company Kemira, with alumina and aluminium stearate, such as the product Microtitanium Dioxide MT 100 TV, MT 100 TX, MT 100 Z and MT-01 from the company Tayca, and the products Solaveil CT-10 W, Solaveil CT 100 and Solaveil CT 200 from the company Uniqema,
with silica, alumina and alginic acid, such as the product MT-100 AQ from the company Tayca,
with alumina and aluminium laurate, such as the product Microtitanium Dioxide MT 100 S from the company Tayca,
with iron oxide and iron stearate, such as the product Microtitanium Dioxide MT 100 F from the company Tayca,
with zinc oxide and zinc stearate, such as the product BR351 from the company Tayca,
with silica and alumina and treated with a silicone, such as the products Microtitanium Dioxide MT 600 SAS, Microtitanium Dioxide MT 500 SAS or Microtitanium Dioxide MT 100 SAS from the company Tayca,
with silica, alumina and aluminium stearate and treated with a silicone, such as the product STT-30-DS from the company Titan Kogyo,
with silica and treated with a silicone, such as the product UV-Titan X 195 from the company Kemira, or the product SMT-100 WRS from the company Tayca, with alumina and treated with a silicone, such as the products Tipaque TTO-55 (S) from the company Ishihara or UV Titan M 262 from the company Kemira, with triethanolamine, such as the product STT-65-S from the company Titan Kogyo,
with stearic acid, such as the product Tipaque TTO-55 (C) from the company Ishihara,
with sodium hexametaphosphate, such as the product Microtitanium Dioxide MT 150 W from the company Tayca. Other titanium oxide pigments treated with a silicone are, for example, T1O2 treated with octyltrimethylsilane, such as the product sold under the trade name T 805 by the company Degussa Silicas, T1O2 treated with a polydimethylsiloxane, such as the product sold under the trade name 70250 Cardre UF TiO2SI3 by the company Cardre, anatase/rutile T1O2 treated with a polydimethylhydrogenosiloxane, such as the product sold under the trade name Microtitanium Dioxide USP Grade Hydrophobic by the company Color Techniques.
The uncoated titanium oxide pigments are sold, for example, by the company Tayca under the trade names Microtitanium Dioxide MT 500 B or Microtitanium Dioxide MT 600 B, by the company Degussa under the name P 25, by the company Wacker under the name Transparent titanium oxide PW, by the company Miyoshi Kasei under the name UFTR, by the company Tomen under the name ITS and by the company Tioxide under the name Tioveil AQ.
The uncoated zinc oxide pigments are, for example:
- those sold under the name Z-Cote by the company Sunsmart;
- those sold under the name Nanox by the company Elementis;
- those sold under the name Nanogard WCD 2025 by the company Nanophase Technologies.
The coated zinc oxide pigments are, for example:
- those sold under the name Z-Cote HP1 by the company Sunsmart (dimethicone-coated ZnO);
- those sold under the name Zinc Oxide CS-5 by the company Toshibi (ZnO coated with polymethylhydrogenosiloxane);
- those sold under the name Nanogard Zinc Oxide FN by the company Nanophase Technologies (as a 40% dispersion in Finsolv TN, C12-C15 alkyl benzoate);
- those sold under the name Daitopersion ZN-30 and Daitopersion ZN-50 by the company Daito (dispersions in cyclopolymethylsiloxane/oxyethylenated polydimethylsiloxane, containing 30% or 50% of nanozinc oxides coated with silica and polymethylhydrogenosiloxane);
- those sold under the name NFD Ultrafine ZnO by the company Daikin (ZnO coated with perfluoroalkyl phosphate and copolymer based on perfluoroalkylethyl as a dispersion in cyclopentasiloxane);
- those sold under the name SPD-Z1 by the company Shin-Etsu (ZnO coated with silicone-grafted acrylic polymer, dispersed in cyclodimethylsiloxane);
- those sold under the name Escalol Z100 by the company ISP (alumina-treated ZnO dispersed in an ethylhexyl methoxycinnamate/PVP-hexadecene/methicone copolymer mixture);
- those sold under the name Fuji ZnO-SMS-10 by the company Fuji Pigment (ZnO coated with silica and polymethylsilsesquioxane);
- those sold under the name Nanox Gel TN by the company Elementis (ZnO dispersed at a concentration of 55% in C12-C15 alkyl benzoate with hydroxystearic acid polycondensate).
The uncoated cerium oxide pigments are sold, for example, under the name Colloidal Cerium Oxide by the company Rhone-Poulenc.
The uncoated iron oxide nanopigments are sold, for example, by the company Arnaud under the names Nanogard WCD 2002 (FE 45B), Nanogard Iron FE 45 BL AQ, Nanogard FE 45R AQ and Nanogard WCD 2006 (FE 45R) or by the company Mitsubishi under the name TY-220, The coated iron oxide pigments are sold, for example, by the company Arnaud under the names Nanogard WCD 2008 (FE 45B FN), Nanogard WCD 2009 (FE 45B 556), Nanogard FE 45 BL 345 and Nanogard FE 45 BL or by the company BASF under the name Transparent Iron Oxide.
Mention may also be made of mixtures of metal oxides, especially of titanium dioxide and of cerium dioxide, including the silica-coated equal-weight mixture of titanium dioxide and of cerium dioxide, sold by the company Ikeda under the name Sunveil A, and also the alumina, silica and silicone-coated mixture of titanium dioxide and of zinc dioxide, such as the product M 261 sold by the company Kemira, or the alumina, silica and glycerol -coated mixture of titanium dioxide and of zinc dioxide, such as the product M 21 1 sold by the company Kemira. The additional UV-screening agents are generally present in the compositions according to the invention in proportions ranging from 0.01 % to 20% by weight relative to the total weight of the composition, and preferably ranging from 0.1 % to 10% by weight relative to the total weight of the composition. The compositions in accordance with the present invention may also comprise standard cosmetic adjuvants chosen especially from oils, waxes, organic solvents, ionic or nonionic, hydrophilic or lipophilic thickeners, softeners, humectants, opacifiers, stabilizers, emollients, silicones, antifoams, fragrances, preserving agents, anionic, cationic, nonionic, zwitterionic or amphoteric surfactants, active agents, fillers, polymers, propellants, acidifying or basifying agents or any other ingredient usually used in cosmetics and/or dermatology.
Oils that may be mentioned include mineral oils (paraffin); plant oils (sweet almond oil, macadamia oil, blackcurrant seed oil or jojoba oil); synthetic oils, for instance perhydrosqualene, fatty alcohols, fatty amides (for instance isopropyl lauroyl sarcosinate sold under the name Eldew SL-205 by the company Ajinomoto), fatty acids or fatty esters, for instance the C12-C15 alkyl benzoate sold under the trade name Finsolv TN or Witconol TN by the company Witco, 2- ethylphenyl benzoate, for instance the commercial product sold under the name X-Tend 226® by the company ISP, octyl palmitate, isopropyl lanolate and triglycerides, including capric/caprylic acid triglycerides, and dicaprylyl carbonate sold under the name Cetiol CC by the company Cognis, oxyethylenated or oxypropylenated fatty esters and ethers; silicone oils (cyclomethicone and polydimethylsiloxanes, or PDMS) or fluoro oils, polyalkylenes, and trialkyl trimellitates such as tridecyl trimellitate.
Examples of waxy compounds that may be mentioned include carnauba wax, beeswax, hydrogenated castor oil, polyethylene waxes and polymethylene waxes, for instance the product sold under the name Cirebelle 303 by the company Sasol.
Among the organic solvents that may be mentioned are lower alcohols and polyols. These polyols may be chosen from glycols and glycol ethers, for instance ethylene glycol, propylene glycol, butylene glycol, dipropylene glycol or diethylene glycol. Hydrophilic thickeners that may be mentioned include carboxyvinyl polymers, such as Carbopols (Carbomers) and the Pemulens (acrylate/C10-C30-alkyl acrylate copolymer); polyacrylamides, for instance the crosslinked copolymers sold under the names Sepigel 305 (CTFA name: polyacrylamide/C13-14 isoparaffin/Laureth 7) or Simulgel 600 (CTFA name: : acrylamide/sodium acryloyldimethyltaurate copolymer/isohexadecane/polysorbate 80) by the company SEPPIC; 2-acrylamido-2-methylpropanesulfonic acid polymers and copolymers, optionally crosslinked and/or neutralized, for instance poly(2- acrylamido-2-methylpropanesulfonic acid) sold by the company Hoechst under the trade name Hostacerin AMPS (CTFA name: ammonium polyacryloyldimethyl taurate or Simulgel 800 sold by the company SEPPIC (CTFA name: sodium polyacryolyldimethyltaurate/polysorbate 80/sorbitan oleate); copolymers of 2-acrylamido-2-methylpropanesulfonic acid and of hydroxyethyl acrylate, for instance Simulgel NS and Sepinov EMT 10 sold by the company SEPPIC; cellulose derivatives such as hydroxyethylcellulose; polysaccharides and especially gums such as xanthan gum; water-soluble or water-dispersible silicone derivatives, for instance acrylic silicones, polyether silicones and cationic silicones, and mixtures thereof.
Lipophilic thickeners that may be mentioned include synthetic polymers, such as the poly(C10-C30 alkyl acrylates) sold under the names Intelimer IPA 13-1 and Intelimer IPA 13-6 by Landec, or modified clays, such as hectorite and its derivatives, for instance the products sold under the name Bentone.
Needless to say, a person skilled in the art will take care to select the optional additional compound(s) mentioned above and/or the amounts thereof such that the advantageous properties intrinsically associated with the compositions in accordance with the invention are not, or are not substantially, adversely affected by the envisaged addition(s), especially the improvement in the photostability of the dibenzoylmethane derivative.
The compositions according to the invention may be prepared according to the techniques that are well known to those skilled in the art. They may in particular be in the form of a simple or complex emulsion (O/W, W/O, O/W/O or W/O/W) such as a cream, a milk or a cream-gel; in the form of an aqueous gel; in the form of a lotion. They may optionally be packaged as an aerosol and may be in the form of a mousse or a spray. The compositions according to the invention are preferably in the form of an oil- in-water or water-in-oil emulsion.
The emulsification processes that may be used are of paddle or impeller, rotor- stator and high-pressure homogenizer (HPH) type.
It is also possible, via HPH (between 50 and 800 bar), to obtain stable dispersions with drop sizes that may be as small as 100 nm.
The emulsions generally contain at least one emulsifying surfactant chosen from amphoteric, anionic, cationic and nonionic emulsifying surfactants, which are used alone or as a mixture. The emulsifiers are appropriately chosen according to the emulsion to be obtained (W/O or O/W).
As emulsifying surfactants that may be used for the preparation of the W/O emulsions, examples that may be mentioned include sorbitan, glycerol or sugar alkyl esters or ethers; silicone surfactants, for instance dimethicone copolyols, such as the mixture of cydomethicone and of dimethicone copolyol, sold under the name DC 5225 C by the company Dow Corning, and alkyldimethicone copolyols such as laurylmethicone copolyol sold under the name Dow Corning 5200 Formulation Aid by the company Dow Corning; cetyl-dimethicone copolyol, such as the product sold under the name Abil EM 90R by the company Goldschmidt, and the mixture of cetyldimethicone copolyol, of polyglyceryl isostearate (4 mol) and of hexyl laurate, sold under the name Abil WE 09 by the company Goldschmidt. One or more co-emulsifiers may also be added thereto, which may be chosen advantageously from the group comprising polyol alkyl esters.
Polyol alkyl esters that may especially be mentioned include polyethylene glycol esters, for instance PEG-30 dipolyhydroxystearate, such as the product sold under the name Arlacel P135 by the company ICI.
Glycerol and/or sorbitan esters that may especially be mentioned include, for example, polyglyceryl isostearate, such as the product sold under the name Isolan Gl 34 by the company Goldschmidt, sorbitan isostearate, such as the product sold under the name Arlacel 987 by the company ICI, sorbitan glyceryl isostearate, such as the product sold under the name Arlacel 986 by the company ICI, and mixtures thereof.
For the O/W emulsions, examples of emulsifiers that may be mentioned include nonionic emulsifiers such as oxyalkylenated (more particularly polyoxyethylenated) fatty acid esters of glycerol; oxyalkylenated fatty acid esters of sorbitan; oxyalkyl-enated (oxyethylenated and/or oxypropylenated) fatty acid esters, for instance the mixture PEG-100 stearate/glyceryl stearate sold, for example, by the company ICI under the name Arlacel 165; oxyalkylenated (oxyethylenated and/or oxypropylenated) fatty alkyl ethers; sugar esters, for instance sucrose stearate; fatty alkyl ethers of sugars, especially polyalkylglucosides (APG) such as decylglucoside and laurylglucoside sold, for example, by the company Henkel under the respective names Plantaren 2000 and Plantaren 1200, cetostearyl glucoside optionally as a mixture with cetostearyl alcohol, sold, for example, under the name Montanov 68 by the company SEPPIC, under the name Tegocare CG90 by the company Goldschmidt and under the name Emulgade KE3302 by the company Henkel, and also arachidyl glucoside, for example in the form of a mixture of arachidyl alcohol, behenyl alcohol and arachidyl glucoside, sold under the name Montanov 202 by the company SEPPIC. According to a specific embodiment of the invention, the mixture of the alkyl polyglucoside as defined above with the corresponding fatty alcohol can be in the form of a self-emulsifying composition, for example as disclosed in the document WO-A-92/06778. When it is an emulsion, the aqueous phase of this emulsion may comprise a nonionic vesicular dispersion prepared according to known processes (Bangham, Standish and Watkins, J. Mol. Biol. 13, 238 (1965), FR 2 315 991 and FR 2 416 008).
The compositions according to the invention find their application in a large number of treatments, especially cosmetic treatments, of the skin, the lips and the hair, including the scalp, especially for protecting and/or caring for the skin, the lips and/or the hair, and/or for making up the skin and/or the lips.
Another subject of the present invention consists of the use of the compositions according to the invention as defined above for the manufacture of cosmetic products for treating the skin, the lips, the nails, the hair, the eyelashes, the eyebrows and/or the scalp, especially care products, antisun products and makeup products.
The cosmetic compositions according to the invention may be used, for example, as makeup products. The cosmetic compositions according to the invention may be used, for example, as care products and/or antisun protection products for the face and/or the body, of liquid to semi-liquid consistency, such as milks, more or less rich creams, cream-gels and pastes. They may optionally be packaged as an aerosol and may be in the form of a mousse or a spray.
The compositions according to the invention in the form of vaporizable fluid lotions in accordance with the invention are applied to the skin or the hair in the form of fine particles by means of pressurization devices. The devices in accordance with the invention are well known to those skilled in the art and comprise non-aerosol pumps or "atomizers", aerosol containers comprising a propellant and also aerosol pumps using compressed air as propellant. These devices are described in patents US 4 077 441 and US 4 850 517 (which form an integral part of the content of the description). The compositions conditioned in aerosol form in accordance with the invention generally contain conventional propellants, for instance hydrofluoro compounds, dichlorodifluoromethane, difluoroethane, dimethyl ether, isobutane, n-butane, propane or trichlorofluoromethane. They are preferably present in amounts ranging from 15% to 50% by weight relative to the total weight of the composition.
The compositions according to the invention may also comprise additional cosmetic or dermatological active agents. Mention may be made, among active agents, of:
- vitamins (A, C, E, K, PP, and the like) and their derivatives or precursors, alone or as mixtures;
- anti-ageing agents;
- antioxidants;
- free-radical scavengers; - antiglycation agents;
- calmatives;
- NO-synthase inhibitors;
- agents for stimulating the synthesis of dermal or epidermal macromolecules and/or for preventing their degradation;
- agents for stimulating fibroblast proliferation;
- agents for stimulating keratinocyte proliferation;
- dermorelaxants;
- tensioning agents;
- matting agents;
- keratolytic agents;
- desquamating agents;
- moisturizers, for instance polyols such as glycerol, butylene glycol or propylene glycol;
- antiinflammatory agents;
- agents that act on the energy metabolism of cells;
- insect repellents;
- substance P or substance CRGP antagonists;
- hair-loss counteractants and/or hair restorers;
- antiwrinkle agents;
- agents for modifying skin pigmentation;
- astringents;
- seboregulators and antiseborrhoeic agents. Needless to say, a person skilled in the art will take care to select the optional additional compound(s) and/or the amounts thereof such that the advantageous properties intrinsically associated with the compositions in accordance with the invention are not, or are not substantially, adversely affected by the envisaged addition(s).
A person skilled in the art will select the said active agent(s) as a function of the effect desired on the skin, the hair, the eyelashes, the eyebrows and the nails.
The composition may also comprise at least one ingredient such as fillers with a soft-focus effect or agents for promoting the natural coloration of the skin, intended for complementing the biological effects of these active agents or for providing an immediate visual anti-ageing effect.
OTHER ADDITIONAL INGREDIENTS
The composition may also comprise at least one additional ingredient intended to provide an immediate visual effect. Mention may be made especially of agents that promotes the naturally pinkish coloration of the skin. As agents that promote the naturally pinkish coloration of the skin, examples that may be mentioned include self-tanning agents, for instance an agent which, when applied to the skin, especially to the face, makes it possible to obtain a tanning effect more or less similar in appearance to that which may result from prolonged exposure to sunlight (natural tanning) or under a UV lamp. Examples of self-tanning agents that may especially be mentioned include:
dihydroxyacetone (DHA),
erythrulose, and
the combination of a catalytic system formed from:
manganese and/or zinc oxide salts, and
alkali metal and/or alkaline-earth metal hydrogen carbonates.
The self-tanning agents are generally chosen from monocarbonyl or polycarbonyl compounds, for instance isatin, alloxan, ninhydrin, glyceraldehyde, mesotartaric aldehyde, glutaraldehyde, erythrulose, pyrazoline-4,5-dione derivatives as described in patent application FR 2 466 492 and WO 97/35842, dihydroxyacetone (DHA) and 4,4-dihydroxypyrazolin-5-one derivatives as described in patent application EP 903 342. DHA will preferably be used. The DHA may be used in free and/or encapsulated form, for example in lipid vesicles such as liposomes, especially described in patent application WO 97/25970.
In general, the self-tanning agent is present in an amount ranging from 0.01 % to 20% by weight and preferably in an amount of between 0.1 % and 10% of the total weight of the composition.
Other dyes that allow modification of the colour produced by the self-tanning agent may also be used.
These dyes may be chosen from synthetic or natural direct dyes.
These dyes may be chosen, for example, from red or orange dyes of the fluorane type such as those described in patent application FR 2 840 806. Mention may be made, for example, of the following dyes:
- tetrabromofluoresceine or eosin known under the CTFA name: CI 45380 or Red 21
- phloxin B known under the CTFA name: CI 45410 or Red 27
- diiodofluoresceine known under the CTFA name: CI 45425 or Orange 10;
- dibromofluoresceine known under the CTFA name: CI 45370 or Orange 5;
- the sodium salt of tetrabromofluoresceine known under the CTFA name: CI 45380 (Na salt) or Red 22;
- the sodium salt of phloxin B known under the CTFA name: CI 45410 (Na salt) or Red 28;
- the sodium salt of diiodofluoresceine known under the CTFA name: CI 45425 (Na salt) or Orange 1 1 ;
- erythrosine known under the CTFA name: CI 45430 or Acid Red 51 .
- phloxin known under the CTFA name: CI 45405 or Acid Red 98. These dyes may also be chosen from anthraquinones, caramel, carmine, carbon black, azulene blues, methoxalene, trioxalene, guajazulene, chamuzulene, rose Bengal, eosin 10B, cyanosin and daphinin.
These dyes may also be chosen from indole derivatives, for instance the monohydroxyindoles as described in patent FR 2 651 126 (i.e.: 4-, 5-, 6- or 7- hydroxyindole) or the dihydroxyindoles as described in patent EP-B-0 425 324 (i.e.: 5,6-dihydroxyindole, 2-methyl-5,6-dihydroxyindole, 3-methyl-5,6- dihydroxyindole or 2,3-dimethyl-5,6-dihydroxyindole).
EXAMPLES OF SYNTHESIS:
EXAMPLE 1 : Preparation of methyl (2Z,4E)-5-rbis(2-hvdroxyethyl)amino1-2- (methylsulfonyl)penta-2,4-dienoate:
Figure imgf000039_0001
(ab)
First step: Preparation of methyl (2Z,4E)-5-[acetyl(phenyl)amino1-2- (methylsulfonyl)penta-2,4-dienoate:
3-Anilinoacrolein aniline (2 g, 9x10"3 mol) and methylmethanesulfonyl acetate (1 .37 ml, 9x10"3 mol) are heated at 105°C in 5 ml of acetic anhydride for 2 hours 30 minutes. After cooling, the acetic anhydride is evaporated off under vacuum. The brown solid obtained is taken up in 40 ml of methanol and brought to reflux. After cooling, the solid obtained is filtered off, rinsed with cold methanol and dried. 1 .6 g of a yellow powder (yield: 55%) of methyl (2Z,4E)-5- [acetyl(phenyl)amino]-2-(methylsulfonyl)penta-2,4-dienoate are recovered and are used in the following step without further processing.
Second step: Preparation of the compound of Example 1 :
A solution of the preceding product (2.3 g, 7.1x10"3 mol) and of diethanolamine (10.33 g, 6.23x10"3 mol) in 5.5 ml of acetonitrile is refluxed for 1 hour 15 minutes. After cooling, the acetonitrile is evaporated off under vacuum. The brown oil obtained is chromatographed on a column of silica (gradient of eluents: CH2CI2/MeOH 100:0 to 90:10). 0.36 g (yield: 26 %) of clean fractions of the derivative of Example 1 is thus obtained in the form of a pale yellow powder:
m.p: 73-76°C
UV (Ethanol): λ,η3χ = 367 ηηη, Er/o = 2140
EXAMPLE 2: Preparation of bis(4-hvdroxybutyl) Γ(2Ε)-3- (dimethylamino)prop-2-en-1 -ylidene1propanedioate:
Figure imgf000039_0002
First step: Preparation of bis[4-(benzyloxy)butyl1 propanedioate:
A heterogeneous mixture of 4-benzyloxy-1 -butanol (9.5 g, 52.8x10"3 mol) and of malonic acid (2.5 ml, 24x10"3 mol) is brought to 50°C with stirring. The catalyst concentrated H2SO4 (131 μΙ_) is added, and the resulting mixture is left at 40°C for 1 hour. After cooling, the grey residue is taken up in dichloromethane. The organic phase is washed with water (abundant foam). After evaporating off the solvent, the residue obtained is chromatographed on a column of silica to remove the starting alcohol (eluent: 90/10 heptane/EtOAc). 7.5 g (yield: 74%) of clean fractions of bis[4-(benzyloxy)butyl] propanedioate are recovered in the form of a pale yellow oil and are used in the following step without further processing.
Second step: Preparation of bis(4-hvdroxybutyl) propanedioate:
The preceding product (7.5 g, 0.0175 mol) dissolved in 350 ml of ethanol was subjected to continuous reductive hydrogenation (H-cube: 70 mm cartridge of 10% Pd on C; Full H2; 1 ml/min; 40°C). After distilling off the ethanol under vacuum, 4.31 g (yield: 99%) of bis(4-hydroxybutyl) propanedioate are obtained in the form of a colourless oil and are used in the following step without further processing.
Third step: Preparation of the compound of Example 2:
The preceding product (4.31 g, 0.0173 mol) and the catalysts n-octylamine (86 μΙ_, 0.03 eq.) and acetic acid (199 μΙ_, 0.2 eq.) in 20 ml of toluene are brought to reflux in a reactor inertized with nitrogen and on which is mounted Dean-Stark apparatus. N,N-Dimethylacrolein (1 .74 ml, 0.0173 mol) dissolved in 10 ml of toluene is added dropwise to the reaction mixture. After boiling the reaction mixture for 3 hours 30 minutes, the same amounts of catalyst are added and refluxing is continued for 21 hours. After cooling, the solvent is evaporated off under vacuum and the brown oil obtained is chromatographed on a column of silica (gradient of eluents: isopropyl ether/acetone from 30:70 to 70:30). 703 mg (yield: 12 %) of the derivative of Example 2 are thus obtained in the form of an orange-coloured oil:
UV (Ethanol): = 374 nm, Er/o = 1600
EXAMPLE 3: Preparation of 2-(r(2E,4E)-2-cvano-5-(diethylamino)penta-2,4- dienoylloxy!ethanesulfonate sodium salt:
Figure imgf000041_0001
First step: Preparation of sodium 2-{[(2E,4E)-2-cyano-5-(diethylamino)penta- 2,4-dienoyl1oxy)ethanesulfonate:
Thionyl chloride (15 ml) is reacted, with stirring, with cyanoacetic acid (2 g, 0.024 mol) and maintained at 40°C for 2 hours. 50 ml of toluene are added and the mixture is concentrated under vacuum until a residual volume of 10 ml is obtained. The sodium salt of isethionic acid (3.48 g, 0.024 mol) is added thereto and the mixture is maintained at the reflux point of the toluene. The heterogeneous mixture is refluxed for 20 hours. After cooling, the reaction mixture is filtered. The solid is taken up in water and the aqueous phase is washed with ethyl acetate. The aqueous phase is brought to neutral pH with 2N sodium hydroxide. 1 .6 g of a beige-coloured powder containing about 30% by mass of salts are recovered. The sodium salt of 2-{[(2E,4E)-2-cyano-5- (diethylamino)penta-2,4-dienoyl]oxy}ethanesulfonic acid is thus obtained, and is used in the following step without further processing.
Second step: Preparation of the compound of Example 3:
The preceding product (1 g, 0.0032 mol) and the catalysts diethylamine (34 μΙ_, 0.1 eq.) and acetic acid (19 μΙ_, 0.1 eq.) in 5 ml of toluene are brought to reflux in a reactor inertized with nitrogen and on which is mounted Dean-Stark apparatus. N,N-Diethylacrolein (0.41 ml, 0.0032 mol) is added dropwise to the reaction mixture. After boiling the reaction mixture for 3 hours 30 minutes, the same amounts of catalyst are added and refluxing is continued for 21 hours. After cooling, the reaction mixture is filtered and the solid obtained is washed with diisopropyl ether. After chromatography on a reverse-phase column, 212 mg (yield: 22 %) of the derivative of Example 3 are obtained in the form of a beige- coloured solid:
UV (H2O): λπ13χ = 370 ηηη, Er/o = 1200
III/ FORMULATION EXAMPLES
Compositions A and B were prepared:
Ingredients Ex. A Ex. B
EDTA 0.1 0.1
Monopotassium monocetyl 1 1
phosphate
Deionized water qs qs
100 100
Triethanolamine 0.3 0.3
Preserving agents 1 .2 1 .2
C12-C15 alkyl benzoate 20 20
Preserving agents 0.25 0.25
Stearic acid 1 .5 1 .5
Glyceryl 1 1
mono/distearate/polyethylen
e glycol stearate (100 EO)
mixture
Cetyl alcohol 0.5 0.5
Cetearyl alcohol and 2 2
cetearyl glucoside
Dimethicone (350 cSt) 0.5 0.5
Triethanolamine 0.45 0.45
Drometrizole trisiloxane 2 2
Avobenzone (Parsol 1789) 2 2
Merocyanin of formula (y) 1 .5 0
Merocyanin of formula (ac) 0 1 .5
2,4,6-tris[p-(2'-ethylhexyl-1 '- 2 2
oxycarbonyl)anilino]-1 ,3,5- triazine
Isohexadecane 1 1
Copolymer of acrylic acid 0.2 0.2
and of C10-C30 alkyl
methacrylate
Xanthan 0.2 0.2
Cyclopentadimethylsiloxane 5 5

Claims

5 1. Composition comprising, in a cosmetically acceptable support, at least one UV-screening system, characterized in that it comprises:
(a) at least one dibenzoylmethane derivative and
(b) at least one hydrophilic or water-soluble merocyanin UV-screening agent chosen from the group formed by:
o
(1 ) those corresponding to one of the formulae (I) and (II) and also the salts thereof and the Ε,Ε-, Ε,Ζ- or Ζ,Ζ- geometrical isomer forms thereof
below:
Figure imgf000043_0001
in which:
- Ri and R2, which may be identical or different, represent H; a linear or0 branched C1-C22 alkyl radical possibly containing from 1 to 3 oxygen atoms; a
C3-C8 cycloalkyi radical, which is unsubstituted or substituted with Ci-C4 alkyl radicals; the said radicals Ri and R2 possibly containing an alkylsulfonate radical in its acid or salified form or one or two hydroxyl radicals;
- Ri and R2 may form, together with the nitrogen, a ring containing the group -5 (CH2)m-, which is uninterrupted or interrupted with one or more -O-, -S- or -NH-,
- Ri may form, with the carbon alpha to the nitrogen, a ring containing the group -(CH2)m-, which is uninterrupted or interrupted with one or more -O-, -S- or -NH-,
- R3 represents a carboxyl, -COOR5, -CONHR5, -COR5, -CONR5R1 , SO2R5 or - CN group,
0 - R4 represents a carboxyl, -COOR6, -CONHR6, -COR6, -CONR6R2 or SO2R6 group,
- R5 and R6, which may be identical or different, represent a linear or branched C1-C22 alkyl radical possibly containing from 1 to 3 oxygen atoms; a C3-C8 cycloalkyi radical, which is unsubstituted or substituted with Ci-C4 alkyl radicals;5 the said radicals R5 and R6 possibly containing an alkylsulfonate radical in its acid or salified form or one or two hydroxyl radicals,
- Z represents the group -(CH2)r, which is uninterrupted or interrupted with -O-, - S- or -IMR7-, and/or unsubstituted or substituted with one or two C1-C6 alkyl radicals,
0 - R7 is a C1-C5 alkyl radical possibly containing an alkylsulfonate radical in its acid or salified form or one or two hydroxyl radicals,
- n is 1 -2; - m is 1 -7; - 1 is 1 -4; with at least one or two of the radicals Ri , R2, R5, R6 and R7 containing
- either an alkylsulfonate radical in its acid or salified form
- or one or two hydroxyl radicals;
with the proviso that:
(i) when n = 2, one of the radicals Ri , R5 or R6 is an alkyl diradical or Ri and R2 together with two nitrogen atoms form a cyclic divalent radical -(CH2)m-;
(ii) Ri and R2 are not simultaneously a hydrogen atom;
(iii) when R3 is -CN, then at least one of the radicals Ri , R2 or R6 must contain an alkylsulfonate group in its acid or salified form;
(2) the merocyanin compounds chosen from the group formed by the following molecules, and also salts thereof and the Ε,Ε-, Ε,Ζ- or Ζ,Ζ- geometrical isomer forms thereof.
Figure imgf000044_0001
Figure imgf000044_0002
Figure imgf000044_0003
44
Figure imgf000045_0001
Figure imgf000045_0002
Figure imgf000045_0003
Figure imgf000046_0001
46
Figure imgf000047_0001
Figure imgf000047_0002
Figure imgf000047_0003
Figure imgf000047_0004
47
Figure imgf000048_0001
Figure imgf000048_0002
Figure imgf000048_0003
2. Connposition according to Clainn 1 , in which the connpounds of fornnula (I) are chosen from those for which the following conditions are satisfied:
Ri denotes hydrogen; a linear or branched Ci-Cs alkyl radical possibly containing from 1 to 3 oxygen atoms,
R2 denotes a linear or branched Ci-Cs alkyl radical possibly containing from 1 to 3 oxygen atoms or a C5-C6 cycloalkyl radical,
R3 denotes a group -COOR5, -CN or -CONHR5,
R4 denotes a group -COOR6, -CONHR6 or -SO2R6,
R5 denotes a linear or branched C1-C12 alkyl radical possibly containing from 1 to 3 oxygen atoms,
n is equal to 1 or 2;
with at least one or two of the radicals Ri , R2, R5, R6 containing
- either an alkylsulfonate radical in its acid or salified form
- or one or two hydroxyl radicals.
3. Composition according to Claim 2, in which the compounds of formula (I) containing at least one alkylsulfonate group are chosen from those having the following formulae, and also the Ε,Ε, Ζ,Ζ, E,Z isomer forms thereof:
Figure imgf000049_0001
Figure imgf000049_0002
49
Figure imgf000050_0001
Figure imgf000050_0002
Figure imgf000050_0003
Figure imgf000051_0001
Figure imgf000051_0002
4. Connposition according to Clainn 2, in which the compounds of formula (I) containing hydroxyl groups are chosen from those having the following formulae:
Figure imgf000051_0003
Figure imgf000051_0004
Figure imgf000052_0001
5. Connposition according to Claim 1 , in which the compounds of formula (II) are chosen from those for which the following conditions are satisfied:
Ri denotes hydrogen; a linear or branched C1-C10 alkyl radical possibly containing from 1 to 3 oxygen atoms,
R2 denotes a linear or branched C1-C10 alkyl radical possibly containing from 1 to 3 oxygen atoms; a C5-C6 cycloalkyl,
R3 denotes a group -COOR5 or CN,
R4 denotes a group -COOR6 or -SO2R6,
R5 denotes a linear or branched C1-C12 alkyl radical possibly containing from 1 to 3 oxygen atoms,
Z is -(CH2)3- which may or may not be substituted with two groups CH3, n is equal to 1 or 2;
with at least one or two of the radicals Ri, R2, R5, R6 and R7 containing
- either an alkylsulfonate radical in its acid or salified form
- or one or two hydroxyl radicals.
6. Composition according to Claim 5, in which the compounds of formula (II) are chosen from those having the following formulae, and also the Ε,Ε, Ζ,Ζ, E,Z isomer forms thereof:
Figure imgf000052_0002
7. Composition according to any one of Claims 1 to 6, in which the hydrophilic or water-soluble merocyanin UV screening agent(s) are chosen from the following compounds, and also the salts or the Ε,Ε, Ζ,Ζ, E,Z isomer forms thereof: 52
Figure imgf000053_0001
Figure imgf000053_0002
Figure imgf000053_0003
Figure imgf000053_0004
Figure imgf000054_0001
8. Composition according to any one of Claims 1 to 7, in which the dibenzoylmethane derivative is 4-(tert-butyl)-4'-methoxydibenzoylmethane, or Butyl Methoxy Dibenzoylmethane or Avobenzone, having the following formula:
O O
OMe
9. Connposition according to any one of Clainns 1 to 9, characterized in that it also contains other UVA-active and/or UVB-active organic or mineral screening agents, which are water-soluble or liposoluble, or else insoluble in the commonly used cosmetic solvents.
10. Composition according to Claim 9, in which the additional organic screening agents are chosen from anthranilates; cinnamic derivatives; salicylic derivatives; camphor derivatives; benzophenone derivatives; β,β-diphenylacrylate derivatives; triazine derivatives; benzotriazole derivatives; benzalmalonate derivatives; benzimidazole derivatives; imidazolines; bis-benzazolyl derivatives; p-aminobenzoic acid (PABA) derivatives; methylenebis(hydroxyphenylbenzotriazole) derivatives; benzoxazole derivatives; screening polymers and screening silicones; a-alkylstyrene-based dimers; 4,4- diarylbutadienes; liposoluble merocyanin derivatives; and mixtures thereof.
11. Composition according to Claim 10, characterized in that the organic UV- screening agent(s) are chosen from the following compounds:
Ethylhexyl methoxycinnamate,
Homosalate,
Ethylhexyl salicylate,
Octocrylene,
Phenylbenzimidazolesulfonic acid,
Benzophenone-3,
Benzophenone-4,
Benzophenone-5,
n-Hexyl 2-(4-diethylamino-2-hydroxybenzoyl)-benzoate,
1 ,1 '-(1 ,4-Piperazinediyl)bis[1 -[2-[4-(diethylamino)-2- hydroxybenzoyl]phenyl]methanone,
4-Methylbenzylidenecamphor,
Terephthalylidenedicamphorsulfonic acid,
Disodium phenyldibenzimidazoletetrasulfonate,
Ethylhexyl triazone,
Bis(ethylhexyloxyphenol)methoxyphenyltriazine,
Diethylhexylbutamidotriazone,
2,4,6-Tris(biphenyl-4-yl)-1 ,3,5-triazine,
2,4,6-Tris(dineopentyl 4'-aminobenzalmalonate)-s-triazine,
2,4,6-Tris(diisobutyl 4'-aminobenzalmalonate)-s-triazine,
2,4-Bis(dineopentyl 4'-aminobenzalmalonate)-6-(n-butyl 4'-aminobenzoate)-s- triazine,
2,4-Bis(n-butyl 4'-aminobenzoate)-6-[(3-{1 ,3,3,3-tetramethyl-1 -
[(trimethylsilyl)oxy]-disiloxanylpropyl)amino]-s-triazine,
Methylenebis(benzotriazolyl)tetramethylbutylphenol,
Drometrizole trisiloxane,
Polysilicone-15,
Dineopentyl 4'-methoxybenzalmalonate,
1 ,1 -Dicarboxy(2,2'-dimethylpropyl)-4,4-diphenyl-butadiene,
2,4-Bis[5-1 (dimethylpropyl)benzoxazol-2-yl-(4-phenyl)imino]-6-(2- ethylhexyl)imino-1 ,3,5-triazine,
and mixtures thereof,
and mixtures thereof.
12. Composition according to Claim 9, characterized in that the additional mineral screening agents are coated or uncoated metal oxide pigments.
13. Process for improving the chemical stability towards UV radiation of at least one dibenzoylmethane derivative as defined in any one of the preceding claims, characterized in that the said dibenzoylmethane derivative is combined with an effective amount of a combination of at least one hydrophilic or water-soluble merocyanin UV-screening agent or a salt thereof or an Ε,Ε-, Ε,Ζ- or Ζ,Ζ- isomer form thereof as defined in any one of Claims 1 to 7.
14. Merocyanin compound with one or two alkylsulfonate radicals of formula (I) as defined in one of Claims 1 to 3, chosen from the following compounds, and also salts thereof or Ε,Ε-, Ε,Ζ- or Ζ,Ζ- isomer forms thereof:
Figure imgf000056_0001
Figure imgf000056_0002
Figure imgf000057_0001
Figure imgf000057_0002
Figure imgf000057_0003
15. Merocyanin compounds containing hydroxyl groups of formula (I) as defined in either of Claims 1 and 4, chosen from the following compounds, and also salts thereof or Ε,Ε-, Ε,Ζ- or Ζ,Ζ- isomer forms thereof: 57
Figure imgf000058_0001
Figure imgf000058_0002
16. Merocyanin compounds of formula (II) as defined in any one of Claims 1 , 5 and 6, in particular those chosen from the following compounds, and also salts
Figure imgf000059_0001
17. Merocyanin compounds chosen from the following compounds, and also the salts thereof or Ε,Ε-, Ε,Ζ- or Ζ,Ζ- isomer forms thereof:
Figure imgf000059_0002
59
Figure imgf000060_0001
Figure imgf000060_0002
Figure imgf000060_0003
Figure imgf000060_0004
60
Figure imgf000061_0001
Figure imgf000061_0002
Figure imgf000061_0003
Figure imgf000061_0004
Figure imgf000062_0001
Figure imgf000062_0002
Figure imgf000062_0003
Figure imgf000062_0004
Figure imgf000062_0005
62
Figure imgf000063_0001
Figure imgf000063_0002
Figure imgf000063_0003
PCT/EP2011/053376 2010-03-15 2011-03-07 Composition containing a dibenzoylmethane screening agent and a hydrophilic or water-soluble merocyanin uv-screening agent; process for photostabilizing the dibenzoylmethane screening agent WO2011113718A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CN2011800240512A CN102883704A (en) 2010-03-15 2011-03-07 Composition containing a dibenzoylmethane screening agent and a hydrophilic or water-soluble merocyanin uv-screening agent, and a process for the radiation-photostabilization of the dibenzoylmethane screening agent
EP11706614A EP2547313A1 (en) 2010-03-15 2011-03-07 Composition containing a dibenzoylmethane screening agent and a hydrophilic or water-soluble merocyanin uv-screening agent; process for photostabilizing the dibenzoylmethane screening agent
US13/634,194 US9162976B2 (en) 2010-03-15 2011-03-07 Composition containing a dibenzoylmethane screening agent and a hydrophilic or water-soluble merocyanin uv-screening agent; process for photostabilizing the dibenzoylmethane screening agent
JP2012557477A JP2013522259A (en) 2010-03-15 2011-03-07 Composition containing dibenzoylmethane-based blocking agent and hydrophilic or water-soluble merocyanine-based UV blocking agent, and method for photostabilizing dibenzoylmethane-based blocking agent
BR112012023232-0A BR112012023232B1 (en) 2010-03-15 2011-03-07 COMPOSITION, PROCESS TO IMPROVE CHEMICAL STABILITY IN RELATION TO UV RADIATION AND MEROCIANIN COMPOUNDS
US14/845,342 US20160058682A1 (en) 2010-03-15 2015-09-04 Composition containing a dibenzoylmethane screening agent and a hydrophilic or water-soluble merocyanin uv-screening agent; process for photostabilizing the dibenzoylmethane screening agent

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
FR1051823 2010-03-15
FR1051823A FR2957250B1 (en) 2010-03-15 2010-03-15 COMPOSITION CONTAINING DIBENZOYLMETHANE FILTER AND HYDROPHILIC OR WATER SOLUBLE MEROCYANINE UV FILTER; METHOD FOR PHOTOSTABILIZING THE DIBENZOYLMETHANE FILTER
US28273310P 2010-03-24 2010-03-24
US61/282,733 2010-03-24
FR1058690 2010-10-22
FR1058690 2010-10-22
FR1059756A FR2967900B1 (en) 2010-11-25 2010-11-25 COMPOSITION CONTAINING A DIBENZOYLMETHANE FILTER AND A HYDROPHILIC OR WATER-SOLUBLE MEROCYANINE UV FILTER; METHOD FOR PHOTOSTABILIZATION OF THE DIBENZOYLMETHANE FILTER
FR1059756 2010-11-25

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US13/634,194 A-371-Of-International US9162976B2 (en) 2010-03-15 2011-03-07 Composition containing a dibenzoylmethane screening agent and a hydrophilic or water-soluble merocyanin uv-screening agent; process for photostabilizing the dibenzoylmethane screening agent
US14/845,342 Division US20160058682A1 (en) 2010-03-15 2015-09-04 Composition containing a dibenzoylmethane screening agent and a hydrophilic or water-soluble merocyanin uv-screening agent; process for photostabilizing the dibenzoylmethane screening agent

Publications (1)

Publication Number Publication Date
WO2011113718A1 true WO2011113718A1 (en) 2011-09-22

Family

ID=44262973

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/053376 WO2011113718A1 (en) 2010-03-15 2011-03-07 Composition containing a dibenzoylmethane screening agent and a hydrophilic or water-soluble merocyanin uv-screening agent; process for photostabilizing the dibenzoylmethane screening agent

Country Status (6)

Country Link
US (2) US9162976B2 (en)
EP (1) EP2547313A1 (en)
JP (1) JP2013522259A (en)
CN (1) CN102883704A (en)
BR (1) BR112012023232B1 (en)
WO (1) WO2011113718A1 (en)

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013010590A1 (en) * 2011-07-21 2013-01-24 L'oreal Cosmetic and/or dermatological composition containing a merocyanine derivative comprising specific polar groups consisting of hydroxyl- and ether-functionalities
WO2013011480A1 (en) * 2011-07-21 2013-01-24 Basf Se Merocyanine derivatives
FR2983716A1 (en) * 2011-12-12 2013-06-14 Oreal Oil-in-water emulsion used for caring hair, comprises dispersing continuous aqueous phase, dispersed discontinuous oily phase, photoprotector system, hydrophobic polymer of vinyl monomer, nonionic surfactants and ionic water-oil emulsifier
EP2734499A1 (en) * 2011-07-21 2014-05-28 Basf Se Merocyanine derivatives
WO2014111568A1 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological water-in-oil emulsion comprising a merocyanine and at least one emulsifying polymer of the polyoxyalkylenated glycol fatty acid ester type
WO2014111565A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological emulsion comprising a merocyanine and an emulsifying system containing a gemini surfactant
WO2014111566A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an insoluble organic uv-screening agent and/or an insoluble inorganic uv- screening agent
WO2014111569A2 (en) 2013-01-21 2014-07-24 L'oreal Anhydrous cosmetic or dermatological composition comprising a merocyanine and an oily phase
WO2014111562A1 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological emulsion comprising a merocyanine and an emulsifying system containing an alkali metal salt of a phosphoric acid ester of a fatty alcohol
WO2014111567A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine and a uva-screening agent of the amino-substituted 2-hydroxybenzophenone type and/or a hydrophilic organic uva-screening agent
WO2014111563A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine and a lipophilic benzotriazole uv-screening agent and/or a bis-resorcinyl triazine compound
WO2014111564A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine, an oily phase and a c1-c4 monoalkanol
WO2014111574A1 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine, an organic uvb-screening agent and an additional organic uva-screening agent
WO2014111571A1 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological emulsion comprising a merocyanine and an emulsifying system containing an amphiphilic polymer comprising at least one 2-acrylamidomethylpropanesulfonic acid unit
WO2014111570A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one specific amide compound
FR3001135A1 (en) * 2013-01-21 2014-07-25 Oreal Composition, useful for making up keratinous material, and improving color and homogeneity of skin, comprises at least an oil phase, at least one merocyanine compound, and at least one insoluble inorganic UV filter
FR3001141A1 (en) * 2013-01-21 2014-07-25 Oreal Composition, useful in non-therapeutic cosmetic process for caring and/or making up of keratin material e.g. skin, comprises oil phase, merocyanine compounds, triazine UVB filters and organic UV filter different from merocyanine in support
FR3001129A1 (en) * 2013-01-21 2014-07-25 Oreal Composition, useful in non-therapeutic cosmetic process for caring and/ e.g. skin, comprises oil phase, merocyanine compounds, and lipophilic benzotriazole UV filter in support
FR3001130A1 (en) * 2013-01-21 2014-07-25 Oreal Composition, useful in non-therapeutic cosmetic process for caring and/or making up of keratin material e.g. skin, comprises an oil phase, a merocyanine compound, and an insoluble organic UV filter in a medium
FR3001142A1 (en) * 2013-01-21 2014-07-25 Oreal Composition in the form of emulsion, useful in non-therapeutic cosmetic process for caring and/or making up of keratin material e.g. skin, comprises merocyanine compound, oily phase, aqueous phase, and hydrophilic organic UVA filter
FR3001143A1 (en) * 2013-01-21 2014-07-25 Oreal USE OF A REINFORCED SOLAR PROTECTIVE COMPOSITION IN LIGHT UVA PROTECTION TO PROTECT FROM HERPES PUSH INDUCED BY SOLAR EXPOSURE.
WO2016030839A1 (en) 2014-08-28 2016-03-03 L'oreal Gel composition and gel comprising a uv filter
WO2016083404A1 (en) 2014-11-24 2016-06-02 L'oreal Cosmetic composition comprising a synthetic phyllosilicate and a polyol and/or a uv filter
WO2016198581A1 (en) 2015-06-11 2016-12-15 L'oreal Composition comprising a uv-screening agent, an anionic crosslinked hydrophilic polymer, a surfactant having an hlb less than or equal to 5 and a silicone copolymer
WO2016204947A1 (en) 2015-06-19 2016-12-22 L'oreal Sunscreen composition containing high levels of liposoluble uv filters
WO2017189301A1 (en) 2016-04-29 2017-11-02 L'oreal Uv-a/uv-b sunscreen composition
WO2018115493A1 (en) 2016-12-23 2018-06-28 L'oreal Composition comprising baicalin
WO2018114214A1 (en) 2016-12-21 2018-06-28 L'oreal Water-in-oil emulsion comprising a particular emulsifying system, a lipophilic clay, and an organopolysiloxane elastomer powder coated with a silicone resin
WO2018114213A1 (en) 2016-12-21 2018-06-28 L'oreal Water-in-oil emulsion containing baicalin, a xanthine base, a vitamin b3, and a polyvalent metal cation salt
WO2019096957A1 (en) 2017-11-15 2019-05-23 L'oreal Composition comprising baicalin and a particular acrylic polymer
WO2019096953A1 (en) 2017-11-15 2019-05-23 L'oreal Cosmetic emulsion containing a gemini surfactant and a lipophilic polymer
WO2019209483A1 (en) 2018-04-23 2019-10-31 L'oreal Memory-shape sunscreen composition
FR3090329A1 (en) 2018-12-21 2020-06-26 L'oreal Composition comprising a UV filter, an anionic crosslinked hydrophilic polymer, a surfactant having an HLB less than or equal to 5 and a non-volatile alkane
FR3103705A1 (en) 2019-11-29 2021-06-04 L'oreal A composition comprising a UV filter, a block polymer containing a phosphonic acid group and a hydrocarbon oil
FR3103704A1 (en) 2019-11-29 2021-06-04 L'oreal Composition comprising a UV filter, an ethylenic polymer with a phosphonic acid group and a hydrocarbon oil
WO2021123337A1 (en) 2019-12-20 2021-06-24 L'oreal Retinol-based composition
WO2021123233A1 (en) 2019-12-20 2021-06-24 L'oreal Retinol-based composition
FR3111074A1 (en) 2020-06-08 2021-12-10 L'oreal Retinol-based composition
FR3111075A1 (en) 2020-06-08 2021-12-10 L'oreal Retinol-based composition
FR3115991A1 (en) 2020-11-06 2022-05-13 L'oreal Solid anhydrous composition comprising a lipophilic organic UV filter, a hydrocarbon oil, and at least 10% of a high melting point wax

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3106128A1 (en) * 2018-07-17 2020-01-23 Evonik Operations Gmbh Ch-acidic methacrylic esters for the preparation of aqueous polymer dispersions
CA3106334C (en) 2018-07-17 2023-07-18 Evonik Operations Gmbh Method for preparing c-h acidic (meth)acrylates
CN109796382A (en) * 2019-02-27 2019-05-24 江苏南大光电材料股份有限公司 The salty photo-acid generator of long flexible chain, preparation method and photoetching compositions
CN110420125A (en) * 2019-08-26 2019-11-08 屈威翰 A kind of compound resorcinol liposome and preparation method thereof

Citations (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2463264A (en) 1942-12-23 1949-03-01 Ciba Ltd Derivatives of cyclic amidines and process of making same
FR2315991A1 (en) 1975-06-30 1977-01-28 Oreal METHOD OF MANUFACTURING AQUEOUS DISPERSIONS OF LIPID SPHERULES AND CORRESPONDING NEW COMPOSITIONS
FR2326405A1 (en) 1975-10-03 1977-04-29 Merck Patent Gmbh NEW DIBENZOYLMETHANE DERIVATIVES USEFUL AS ANTI-SUN COSMETIC AGENTS
US4045229A (en) 1974-09-17 1977-08-30 Eastman Kodak Company Novel UV absorbing compounds and photographic elements containing UV absorbing compounds
US4077441A (en) 1976-08-16 1978-03-07 National Instrument Company Convertible filling machine
FR2416008A1 (en) 1978-02-02 1979-08-31 Oreal LIPOSOME LYOPHILISATES
US4195999A (en) 1977-04-15 1980-04-01 Fuji Photo Film Co., Ltd. Silver halide photographic material containing ultraviolet light absorbing agent
FR2440933A1 (en) 1978-11-13 1980-06-06 Givaudan & Cie Sa DIBENZOYLMETHANE DERIVATIVE AS A LIGHT PROTECTIVE AGENT
FR2466492A1 (en) 1979-10-03 1981-04-10 Elf Aquitaine Dyeing keratin substances, e.g. skin, nails, hair, fur - with compsns. contg. ketone or aldehyde dye and sulphoxy-aminoacid
EP0114607A1 (en) 1983-01-22 1984-08-01 Haarmann & Reimer Gmbh Dibenzoyl methane derivatives, process for their production and their use
EP0133981A2 (en) 1983-08-05 1985-03-13 Siemens Aktiengesellschaft Mechanical overload protection
US4850517A (en) 1985-09-27 1989-07-25 Airspray International B.V. Pressurized spray dispenser having valved mixing chamber
FR2651126A1 (en) 1989-08-29 1991-03-01 Oreal ASSOCIATION OF DIHYDROXYACETONE AND INDOLIC DERIVATIVES FOR CONFERRING TO THE SKIN A COLORATION SIMILAR TO NATURAL TANNING AND METHOD FOR IMPLEMENTING THE SAME.
WO1992006778A1 (en) 1990-10-17 1992-04-30 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Use of fatty alcohol based compositions for preparing emulsions, method of preparing emulsions and emulsions so obtained
US5166355A (en) 1991-02-04 1992-11-24 Fairmount Chemical Co., Inc. Process for preparing substituted 2,2'-methylene-bis-[6-(2H-benzotriazol-2-yl)-4-hydrocarbyl-phenols]
WO1993004665A1 (en) 1991-08-29 1993-03-18 L'oreal Filtering cosmetic composition containing a liposoluble filter polymer with hydrocarbonated structure and a filter silicone
US5237071A (en) 1991-01-22 1993-08-17 Fairmount Chemical Company, Inc. Process for preparing 2,2'-methylene-bis(6-(2H-benzotriazol-2-yl)-4-hydrocarbyl phenols)
EP0669323A1 (en) 1994-02-24 1995-08-30 Haarmann & Reimer Gmbh Utilization of benzazols as UV-absorbers, new benzazoles and process for their preparation
GB2303549A (en) 1995-07-22 1997-02-26 Ciba Geigy Ag Micronising organic UV absorbers with alkyl polyglucosides
US5624663A (en) 1987-08-28 1997-04-29 L'oreal Photostable cosmetic filter composition cotaining a UV-A filter and a substituted dialkylbenzalmalonate, the use of substituted dialkylbenzalmalonates in cosmetics as broad-band solar filters and novel substituted dialkyl malonates
WO1997025970A1 (en) 1996-01-17 1997-07-24 Lancaster Group Gmbh Cosmetic self-tanning agent having a sunscreen effect
WO1997035842A1 (en) 1996-03-22 1997-10-02 L'oreal Cosmetic compositions containing pyrazolin-4,5-diones, novel pyrazolin-4,5-diones, preparation methods therefor and uses thereof
EP0832642A2 (en) 1996-09-13 1998-04-01 3V SIGMA S.p.A Derivatives of Benzoxazole useful as uv filters
DE19726184A1 (en) 1997-06-20 1998-12-24 Beiersdorf Ag Oil-in-water or multiple emulsion with high concentration of suspended UVB filter
EP0893119A1 (en) 1997-07-26 1999-01-27 Ciba SC Holding AG UV-protection formulation
DE19746654A1 (en) 1997-08-13 1999-02-18 Basf Ag Use of 4,4-di:aryl-butadiene derivatives as photostable UV filter compounds
EP0903342A1 (en) 1997-09-19 1999-03-24 L'oreal 4,4-Dihydroxypyrazolin-5-one compounds, procedures for their preparation and their use as cosmetics
DE19755649A1 (en) 1997-12-15 1999-06-17 Basf Ag Use of 4,4-diarylbutadienes as photostable UV filters in cosmetics
EP0967200A1 (en) 1998-06-26 1999-12-29 Basf Aktiengesellschaft 4,4-Diarylbutadienes as water soluble, photostable UV-filters for cosmetic and pharmaceutical preparations
WO2000007989A1 (en) 1998-07-31 2000-02-17 Basf Aktiengesellschaft Method for producing 2-halogen nicotinic acid derivatives and 2-chloronicotinic acid-n-butyl esters as intermediate products
DE19855649A1 (en) 1998-12-03 2000-06-08 Basf Ag Dimeric alpha-alkyl-styrene derivatives as photostable UV filters in cosmetic and pharmaceutical preparations
EP1008586A1 (en) 1998-12-11 2000-06-14 Basf Aktiengesellschaft Oligomeric diarylbutadienes
EP1027883A2 (en) 1999-01-11 2000-08-16 3V SIGMA S.p.A Combinations of sunscreen agents with UV-A and UV-B filtering properties
WO2001028732A1 (en) 1999-10-19 2001-04-26 Norsk Hydro Asa Friction stir spot welding method and apparatus
US6225467B1 (en) 2000-01-21 2001-05-01 Xerox Corporation Electroluminescent (EL) devices
EP1133980A2 (en) 2000-03-15 2001-09-19 Basf Aktiengesellschaft Use of combinations of photoprotectors comprising as essential components aminosubstituted hydroxybenzophenones as photostable UV-filters in cosmetic and pharmaceutical preparations
EP1300137A2 (en) 2001-10-02 2003-04-09 3V SIGMA S.p.A Combinations of sunscreens
DE10162844A1 (en) 2001-12-20 2003-07-03 Beiersdorf Ag Cosmetic and dermatological light protection formulations containing bis-resorcinyltriazine derivatives and benzoxazole derivatives
FR2840806A1 (en) 2002-06-13 2003-12-19 Oreal A red or orange colored cosmetic composition used for artificial suntanning of the skin comprising a mono- or polycarbonylated autobronzing agent such as dihydroxyacetone and a fluorane or fluorane alkali metal salt colorant
WO2004006878A1 (en) 2002-07-10 2004-01-22 Ciba Specialty Chemicals Holding Inc. Merocyanine derivatives for cosmetic use
WO2004075871A1 (en) * 2003-02-26 2004-09-10 Fuji Photo Film B.V. Cosmetic uv-screen compositions and aminobutadiene-based uv-absorbing complexes therefor
WO2004085412A2 (en) 2003-03-24 2004-10-07 Ciba Specialty Chemicals Holding Inc. Symmetrical triazine derivatives
WO2005058269A1 (en) 2003-12-17 2005-06-30 Ciba Specialty Chemicals Holding Inc. Merocyanine derivatives for cosmetic use
GB2416351A (en) * 2004-06-29 2006-01-25 Ciba Sc Holding Ag Use of myocyanine derivatives for the protection of human hair and skin from UV radiation
WO2006032741A1 (en) 2004-09-20 2006-03-30 L'oréal Silane merocyanine sulphone derivatives; photoprotecting compositions containing same; use thereof as uv filter
WO2006035000A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag Sun protection emulsion comprising a high fraction of sun protection filter pigments
WO2006034992A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag Cosmetic sunscreen emulsions containing organic micropigments
WO2006035007A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag Cosmetic light-block preparation made from micropigments
WO2006034982A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag Light-block concentrate with organic micropigments
WO2006034985A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag O/w emulsion comprising inorganic uv filter pigments and alkyl sulfate
WO2006034991A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag W/o emulsion comprising uv filter pigments
WO2006125676A1 (en) * 2005-05-27 2006-11-30 L'oreal Method for photostabilizing a dibenzoylmethane derivative using a merocyanine sulphone derivative; photoprotective cosmetic compositions containing said combination
WO2007014848A2 (en) * 2005-07-29 2007-02-08 Ciba Specialty Chemicals Holding Inc. Stabilization of body-care and household products against degradation by uv radiation using merocyanine derivatives
WO2008080645A1 (en) * 2006-10-13 2008-07-10 Ciba Holding Inc. Merocyanine derivatives
WO2008090066A2 (en) 2007-01-25 2008-07-31 Ciba Holding Inc. Stabilization of uv-sensitive active ingredients
US20090170008A1 (en) 2007-12-27 2009-07-02 Fujifilm Corporation Holographic recording composition and holographic recording medium

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58178351A (en) * 1982-04-14 1983-10-19 Fuji Photo Film Co Ltd Photosensitive silver halide material
CN101277674B (en) * 2005-07-29 2013-01-16 西巴特殊化学制品控股公司 Stabilization of body-care and household products against degradation by UV radiation using merocyanine derivatives

Patent Citations (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2463264A (en) 1942-12-23 1949-03-01 Ciba Ltd Derivatives of cyclic amidines and process of making same
US4045229A (en) 1974-09-17 1977-08-30 Eastman Kodak Company Novel UV absorbing compounds and photographic elements containing UV absorbing compounds
FR2315991A1 (en) 1975-06-30 1977-01-28 Oreal METHOD OF MANUFACTURING AQUEOUS DISPERSIONS OF LIPID SPHERULES AND CORRESPONDING NEW COMPOSITIONS
FR2326405A1 (en) 1975-10-03 1977-04-29 Merck Patent Gmbh NEW DIBENZOYLMETHANE DERIVATIVES USEFUL AS ANTI-SUN COSMETIC AGENTS
US4077441A (en) 1976-08-16 1978-03-07 National Instrument Company Convertible filling machine
US4195999A (en) 1977-04-15 1980-04-01 Fuji Photo Film Co., Ltd. Silver halide photographic material containing ultraviolet light absorbing agent
FR2416008A1 (en) 1978-02-02 1979-08-31 Oreal LIPOSOME LYOPHILISATES
FR2440933A1 (en) 1978-11-13 1980-06-06 Givaudan & Cie Sa DIBENZOYLMETHANE DERIVATIVE AS A LIGHT PROTECTIVE AGENT
FR2466492A1 (en) 1979-10-03 1981-04-10 Elf Aquitaine Dyeing keratin substances, e.g. skin, nails, hair, fur - with compsns. contg. ketone or aldehyde dye and sulphoxy-aminoacid
EP0114607A1 (en) 1983-01-22 1984-08-01 Haarmann & Reimer Gmbh Dibenzoyl methane derivatives, process for their production and their use
EP0133981A2 (en) 1983-08-05 1985-03-13 Siemens Aktiengesellschaft Mechanical overload protection
US4850517A (en) 1985-09-27 1989-07-25 Airspray International B.V. Pressurized spray dispenser having valved mixing chamber
US5624663A (en) 1987-08-28 1997-04-29 L'oreal Photostable cosmetic filter composition cotaining a UV-A filter and a substituted dialkylbenzalmalonate, the use of substituted dialkylbenzalmalonates in cosmetics as broad-band solar filters and novel substituted dialkyl malonates
FR2651126A1 (en) 1989-08-29 1991-03-01 Oreal ASSOCIATION OF DIHYDROXYACETONE AND INDOLIC DERIVATIVES FOR CONFERRING TO THE SKIN A COLORATION SIMILAR TO NATURAL TANNING AND METHOD FOR IMPLEMENTING THE SAME.
EP0425324B1 (en) 1989-08-29 1993-10-27 L'oreal Skin-tanning composition containing indole derivatives and dihydroxyacetone
WO1992006778A1 (en) 1990-10-17 1992-04-30 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Use of fatty alcohol based compositions for preparing emulsions, method of preparing emulsions and emulsions so obtained
US5237071A (en) 1991-01-22 1993-08-17 Fairmount Chemical Company, Inc. Process for preparing 2,2'-methylene-bis(6-(2H-benzotriazol-2-yl)-4-hydrocarbyl phenols)
US5166355A (en) 1991-02-04 1992-11-24 Fairmount Chemical Co., Inc. Process for preparing substituted 2,2'-methylene-bis-[6-(2H-benzotriazol-2-yl)-4-hydrocarbyl-phenols]
WO1993004665A1 (en) 1991-08-29 1993-03-18 L'oreal Filtering cosmetic composition containing a liposoluble filter polymer with hydrocarbonated structure and a filter silicone
EP0669323A1 (en) 1994-02-24 1995-08-30 Haarmann & Reimer Gmbh Utilization of benzazols as UV-absorbers, new benzazoles and process for their preparation
GB2303549A (en) 1995-07-22 1997-02-26 Ciba Geigy Ag Micronising organic UV absorbers with alkyl polyglucosides
WO1997025970A1 (en) 1996-01-17 1997-07-24 Lancaster Group Gmbh Cosmetic self-tanning agent having a sunscreen effect
WO1997035842A1 (en) 1996-03-22 1997-10-02 L'oreal Cosmetic compositions containing pyrazolin-4,5-diones, novel pyrazolin-4,5-diones, preparation methods therefor and uses thereof
EP0832642A2 (en) 1996-09-13 1998-04-01 3V SIGMA S.p.A Derivatives of Benzoxazole useful as uv filters
DE19726184A1 (en) 1997-06-20 1998-12-24 Beiersdorf Ag Oil-in-water or multiple emulsion with high concentration of suspended UVB filter
EP0893119A1 (en) 1997-07-26 1999-01-27 Ciba SC Holding AG UV-protection formulation
DE19746654A1 (en) 1997-08-13 1999-02-18 Basf Ag Use of 4,4-di:aryl-butadiene derivatives as photostable UV filter compounds
EP0903342A1 (en) 1997-09-19 1999-03-24 L'oreal 4,4-Dihydroxypyrazolin-5-one compounds, procedures for their preparation and their use as cosmetics
DE19755649A1 (en) 1997-12-15 1999-06-17 Basf Ag Use of 4,4-diarylbutadienes as photostable UV filters in cosmetics
EP0967200A1 (en) 1998-06-26 1999-12-29 Basf Aktiengesellschaft 4,4-Diarylbutadienes as water soluble, photostable UV-filters for cosmetic and pharmaceutical preparations
WO2000007989A1 (en) 1998-07-31 2000-02-17 Basf Aktiengesellschaft Method for producing 2-halogen nicotinic acid derivatives and 2-chloronicotinic acid-n-butyl esters as intermediate products
DE19855649A1 (en) 1998-12-03 2000-06-08 Basf Ag Dimeric alpha-alkyl-styrene derivatives as photostable UV filters in cosmetic and pharmaceutical preparations
EP1008586A1 (en) 1998-12-11 2000-06-14 Basf Aktiengesellschaft Oligomeric diarylbutadienes
EP1027883A2 (en) 1999-01-11 2000-08-16 3V SIGMA S.p.A Combinations of sunscreen agents with UV-A and UV-B filtering properties
WO2001028732A1 (en) 1999-10-19 2001-04-26 Norsk Hydro Asa Friction stir spot welding method and apparatus
US6225467B1 (en) 2000-01-21 2001-05-01 Xerox Corporation Electroluminescent (EL) devices
EP1133980A2 (en) 2000-03-15 2001-09-19 Basf Aktiengesellschaft Use of combinations of photoprotectors comprising as essential components aminosubstituted hydroxybenzophenones as photostable UV-filters in cosmetic and pharmaceutical preparations
EP1300137A2 (en) 2001-10-02 2003-04-09 3V SIGMA S.p.A Combinations of sunscreens
DE10162844A1 (en) 2001-12-20 2003-07-03 Beiersdorf Ag Cosmetic and dermatological light protection formulations containing bis-resorcinyltriazine derivatives and benzoxazole derivatives
FR2840806A1 (en) 2002-06-13 2003-12-19 Oreal A red or orange colored cosmetic composition used for artificial suntanning of the skin comprising a mono- or polycarbonylated autobronzing agent such as dihydroxyacetone and a fluorane or fluorane alkali metal salt colorant
WO2004006878A1 (en) 2002-07-10 2004-01-22 Ciba Specialty Chemicals Holding Inc. Merocyanine derivatives for cosmetic use
WO2004075871A1 (en) * 2003-02-26 2004-09-10 Fuji Photo Film B.V. Cosmetic uv-screen compositions and aminobutadiene-based uv-absorbing complexes therefor
WO2004085412A2 (en) 2003-03-24 2004-10-07 Ciba Specialty Chemicals Holding Inc. Symmetrical triazine derivatives
WO2005058269A1 (en) 2003-12-17 2005-06-30 Ciba Specialty Chemicals Holding Inc. Merocyanine derivatives for cosmetic use
GB2416351A (en) * 2004-06-29 2006-01-25 Ciba Sc Holding Ag Use of myocyanine derivatives for the protection of human hair and skin from UV radiation
WO2006032741A1 (en) 2004-09-20 2006-03-30 L'oréal Silane merocyanine sulphone derivatives; photoprotecting compositions containing same; use thereof as uv filter
WO2006035000A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag Sun protection emulsion comprising a high fraction of sun protection filter pigments
WO2006034992A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag Cosmetic sunscreen emulsions containing organic micropigments
WO2006035007A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag Cosmetic light-block preparation made from micropigments
WO2006034982A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag Light-block concentrate with organic micropigments
WO2006034985A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag O/w emulsion comprising inorganic uv filter pigments and alkyl sulfate
WO2006034991A1 (en) 2004-09-27 2006-04-06 Beiersdorf Ag W/o emulsion comprising uv filter pigments
WO2006125676A1 (en) * 2005-05-27 2006-11-30 L'oreal Method for photostabilizing a dibenzoylmethane derivative using a merocyanine sulphone derivative; photoprotective cosmetic compositions containing said combination
WO2007014848A2 (en) * 2005-07-29 2007-02-08 Ciba Specialty Chemicals Holding Inc. Stabilization of body-care and household products against degradation by uv radiation using merocyanine derivatives
WO2008080645A1 (en) * 2006-10-13 2008-07-10 Ciba Holding Inc. Merocyanine derivatives
WO2008090066A2 (en) 2007-01-25 2008-07-31 Ciba Holding Inc. Stabilization of uv-sensitive active ingredients
US20090170008A1 (en) 2007-12-27 2009-07-02 Fujifilm Corporation Holographic recording composition and holographic recording medium

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BANGHAM; STANDISH; WATKINS, J. MOL. BIOL., vol. 13, 1965, pages 238
COSMETICS & TOILETRIES, vol. 105, February 1990 (1990-02-01), pages 53 - 64

Cited By (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140294743A1 (en) * 2011-07-21 2014-10-02 L'oreal Cosmetic and/or dermatological composition containing a merocyanine derivative comprising specific polar groups consisting of hydroxyl- and ether-functionalities
WO2013011480A1 (en) * 2011-07-21 2013-01-24 Basf Se Merocyanine derivatives
WO2013011094A3 (en) * 2011-07-21 2013-06-06 L'oreal Cosmetic and/or dermatological composition containing a merocyanine derivative comprising specific polar groups consisting of hydroxyl- and ether-functionalities
EP2734499A1 (en) * 2011-07-21 2014-05-28 Basf Se Merocyanine derivatives
US11458083B2 (en) 2011-07-21 2022-10-04 L'oreal Cosmetic and/or dermatological composition containing a merocyanine derivative comprising specific polar groups consisting of hydroxyl- and ether-functionalities
AU2012285709B2 (en) * 2011-07-21 2017-03-02 L'oreal Cosmetic and/or dermatological composition containing a merocyanine derivative comprising specific polar groups consisting of hydroxyl- and ether-functionalities
US9550730B2 (en) 2011-07-21 2017-01-24 Basf Se Merocyanine derivatives
WO2013010590A1 (en) * 2011-07-21 2013-01-24 L'oreal Cosmetic and/or dermatological composition containing a merocyanine derivative comprising specific polar groups consisting of hydroxyl- and ether-functionalities
EP2734499A4 (en) * 2011-07-21 2015-04-08 Basf Se Merocyanine derivatives
FR2983716A1 (en) * 2011-12-12 2013-06-14 Oreal Oil-in-water emulsion used for caring hair, comprises dispersing continuous aqueous phase, dispersed discontinuous oily phase, photoprotector system, hydrophobic polymer of vinyl monomer, nonionic surfactants and ionic water-oil emulsifier
CN105188653A (en) * 2013-01-21 2015-12-23 莱雅公司 Cosmetic or dermatological composition comprising a merocyanine and a lipophilic benzotriazole UV-screening agent and/or a bis-resorcinyl triazine compound
JP2016505034A (en) * 2013-01-21 2016-02-18 ロレアル Cosmetic or dermatological composition comprising merocyanine, organic UVB screening agent and additional organic UVA screening agent
WO2014111564A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine, an oily phase and a c1-c4 monoalkanol
WO2014111574A1 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine, an organic uvb-screening agent and an additional organic uva-screening agent
WO2014111571A1 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological emulsion comprising a merocyanine and an emulsifying system containing an amphiphilic polymer comprising at least one 2-acrylamidomethylpropanesulfonic acid unit
WO2014111570A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one specific amide compound
FR3001135A1 (en) * 2013-01-21 2014-07-25 Oreal Composition, useful for making up keratinous material, and improving color and homogeneity of skin, comprises at least an oil phase, at least one merocyanine compound, and at least one insoluble inorganic UV filter
FR3001216A1 (en) * 2013-01-21 2014-07-25 Oreal COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING MEROCYANINE, OILY PHASE AND MONO-ALKANOL C1-C4
FR3001141A1 (en) * 2013-01-21 2014-07-25 Oreal Composition, useful in non-therapeutic cosmetic process for caring and/or making up of keratin material e.g. skin, comprises oil phase, merocyanine compounds, triazine UVB filters and organic UV filter different from merocyanine in support
FR3001133A1 (en) * 2013-01-21 2014-07-25 Oreal COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE COMPRISING AT LEAST ONE PARTICULATE AMIDE COMPOUND
FR3001129A1 (en) * 2013-01-21 2014-07-25 Oreal Composition, useful in non-therapeutic cosmetic process for caring and/ e.g. skin, comprises oil phase, merocyanine compounds, and lipophilic benzotriazole UV filter in support
FR3001130A1 (en) * 2013-01-21 2014-07-25 Oreal Composition, useful in non-therapeutic cosmetic process for caring and/or making up of keratin material e.g. skin, comprises an oil phase, a merocyanine compound, and an insoluble organic UV filter in a medium
FR3001142A1 (en) * 2013-01-21 2014-07-25 Oreal Composition in the form of emulsion, useful in non-therapeutic cosmetic process for caring and/or making up of keratin material e.g. skin, comprises merocyanine compound, oily phase, aqueous phase, and hydrophilic organic UVA filter
FR3001143A1 (en) * 2013-01-21 2014-07-25 Oreal USE OF A REINFORCED SOLAR PROTECTIVE COMPOSITION IN LIGHT UVA PROTECTION TO PROTECT FROM HERPES PUSH INDUCED BY SOLAR EXPOSURE.
FR3001136A1 (en) * 2013-01-21 2014-07-25 Oreal COSMETIC OR DERMATOLOGICAL EMULSION COMPRISING A MEROCYANINE AND AN EMULSIFIER SYSTEM CONTAINING AN AMPHIPHILIC POLYMER COMPRISING AT LEAST ONE ACRYLAMIDO 2-METHYLPROPANE SULFONIC ACIDIC PATTERN
FR3001138A1 (en) * 2013-01-21 2014-07-25 Oreal COSMETIC OR DERMATOLOGICAL ANHYDROUS COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE
WO2014111567A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine and a uva-screening agent of the amino-substituted 2-hydroxybenzophenone type and/or a hydrophilic organic uva-screening agent
WO2014111563A3 (en) * 2013-01-21 2014-11-20 L'oreal Cosmetic or dermatological composition comprising a merocyanine and a lipophilic benzotriazole uv-screening agent and/or a bis-resorcinyl triazine compound
WO2014111566A3 (en) * 2013-01-21 2014-11-20 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an insoluble organic uv-screening agent and/or an insoluble inorganic uv- screening agent
WO2014111567A3 (en) * 2013-01-21 2014-12-11 L'oreal Cosmetic or dermatological composition comprising a merocyanine and a uva-screening agent of the amino-substituted 2-hydroxybenzophenone type and/or a hydrophilic organic uva-screening agent
WO2014111570A3 (en) * 2013-01-21 2015-01-15 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one specific amide compound
WO2014111564A3 (en) * 2013-01-21 2015-02-19 L'oreal Cosmetic or dermatological composition comprising a merocyanine, an oily phase and a c1-c4 monoalkanol
WO2014111569A3 (en) * 2013-01-21 2015-02-19 L'oreal Anhydrous cosmetic or dermatological composition comprising a merocyanine and an oily phase
WO2014111562A1 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological emulsion comprising a merocyanine and an emulsifying system containing an alkali metal salt of a phosphoric acid ester of a fatty alcohol
WO2014111588A3 (en) * 2013-01-21 2015-04-23 L'oreal Use of a reinforced anti-sun protection composition in protection against long uva rays for protecting oneself against herpes attacks induced by exposure to the sun
US20150335556A1 (en) * 2013-01-21 2015-11-26 L'oreal Cosmetic or dermatological composition comprising a merocyanine, an oily phase and a c1-c4 monoalkanol
WO2014111569A2 (en) 2013-01-21 2014-07-24 L'oreal Anhydrous cosmetic or dermatological composition comprising a merocyanine and an oily phase
JP2016505031A (en) * 2013-01-21 2016-02-18 ロレアル Cosmetic or dermatological composition comprising merocyanine, oily phase and C1-C4 monoalkanol
JP2016505030A (en) * 2013-01-21 2016-02-18 ロレアル Cosmetic or dermatological composition comprising merocyanine and lipophilic benzotriazole UV screening agent and / or bisresorcinyl triazine compound
JP2016505032A (en) * 2013-01-21 2016-02-18 ロレアル Cosmetic or dermatological composition comprising merocyanine and insoluble organic UV screening agent and / or insoluble inorganic UV screening agent
JP2016505033A (en) * 2013-01-21 2016-02-18 ロレアル Cosmetic or dermatological composition comprising merocyanine and amino-substituted 2-hydroxybenzophenone type UVA screening agent and / or hydrophilic organic UVA screening agent
WO2014111563A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine and a lipophilic benzotriazole uv-screening agent and/or a bis-resorcinyl triazine compound
WO2014111568A1 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological water-in-oil emulsion comprising a merocyanine and at least one emulsifying polymer of the polyoxyalkylenated glycol fatty acid ester type
JP2016508993A (en) * 2013-01-21 2016-03-24 ロレアル Cosmetic or dermatological composition comprising merocyanine and an oily phase comprising at least one specific amide compound
US11000460B2 (en) 2013-01-21 2021-05-11 L'oreal Cosmetic or dermatological composition comprising a merocyanine, an oily phase and a C1—C4 monoalkanol
CN105705131A (en) * 2013-01-21 2016-06-22 莱雅公司 Cosmetic or dermatological composition comprising a merocyanine and an insoluble organic UV-screening agent and/or an insoluble inorganic UV-screening agent
CN105705131B (en) * 2013-01-21 2019-12-17 莱雅公司 Cosmetic or dermatological composition comprising a merocyanine and a UV-screening agent
CN105188653B (en) * 2013-01-21 2019-02-12 莱雅公司 Cosmetics or dermatological compositions comprising merocyanine and lipophilicity benzotriazole UV-smoke agent for shielding and/or double-resorcinol group triaizine compounds
WO2014111566A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological composition comprising a merocyanine and an insoluble organic uv-screening agent and/or an insoluble inorganic uv- screening agent
WO2014111565A2 (en) 2013-01-21 2014-07-24 L'oreal Cosmetic or dermatological emulsion comprising a merocyanine and an emulsifying system containing a gemini surfactant
WO2016030839A1 (en) 2014-08-28 2016-03-03 L'oreal Gel composition and gel comprising a uv filter
WO2016083404A1 (en) 2014-11-24 2016-06-02 L'oreal Cosmetic composition comprising a synthetic phyllosilicate and a polyol and/or a uv filter
WO2016198581A1 (en) 2015-06-11 2016-12-15 L'oreal Composition comprising a uv-screening agent, an anionic crosslinked hydrophilic polymer, a surfactant having an hlb less than or equal to 5 and a silicone copolymer
WO2016204947A1 (en) 2015-06-19 2016-12-22 L'oreal Sunscreen composition containing high levels of liposoluble uv filters
WO2017189301A1 (en) 2016-04-29 2017-11-02 L'oreal Uv-a/uv-b sunscreen composition
WO2018114214A1 (en) 2016-12-21 2018-06-28 L'oreal Water-in-oil emulsion comprising a particular emulsifying system, a lipophilic clay, and an organopolysiloxane elastomer powder coated with a silicone resin
WO2018114213A1 (en) 2016-12-21 2018-06-28 L'oreal Water-in-oil emulsion containing baicalin, a xanthine base, a vitamin b3, and a polyvalent metal cation salt
WO2018115493A1 (en) 2016-12-23 2018-06-28 L'oreal Composition comprising baicalin
WO2019096953A1 (en) 2017-11-15 2019-05-23 L'oreal Cosmetic emulsion containing a gemini surfactant and a lipophilic polymer
WO2019096957A1 (en) 2017-11-15 2019-05-23 L'oreal Composition comprising baicalin and a particular acrylic polymer
US10813875B2 (en) 2018-04-23 2020-10-27 L'oreal Memory shape sunscreen composition
WO2019209483A1 (en) 2018-04-23 2019-10-31 L'oreal Memory-shape sunscreen composition
FR3090329A1 (en) 2018-12-21 2020-06-26 L'oreal Composition comprising a UV filter, an anionic crosslinked hydrophilic polymer, a surfactant having an HLB less than or equal to 5 and a non-volatile alkane
FR3103705A1 (en) 2019-11-29 2021-06-04 L'oreal A composition comprising a UV filter, a block polymer containing a phosphonic acid group and a hydrocarbon oil
FR3103704A1 (en) 2019-11-29 2021-06-04 L'oreal Composition comprising a UV filter, an ethylenic polymer with a phosphonic acid group and a hydrocarbon oil
WO2021123337A1 (en) 2019-12-20 2021-06-24 L'oreal Retinol-based composition
WO2021123233A1 (en) 2019-12-20 2021-06-24 L'oreal Retinol-based composition
FR3104976A1 (en) 2019-12-20 2021-06-25 L'oreal Retinol-based composition
FR3104975A1 (en) 2019-12-20 2021-06-25 L'oreal Retinol-based composition
FR3111074A1 (en) 2020-06-08 2021-12-10 L'oreal Retinol-based composition
FR3111075A1 (en) 2020-06-08 2021-12-10 L'oreal Retinol-based composition
WO2021250001A1 (en) 2020-06-08 2021-12-16 L'oreal Retinol-based composition
WO2021250008A1 (en) 2020-06-08 2021-12-16 L'oreal Retinol-based composition
FR3115991A1 (en) 2020-11-06 2022-05-13 L'oreal Solid anhydrous composition comprising a lipophilic organic UV filter, a hydrocarbon oil, and at least 10% of a high melting point wax

Also Published As

Publication number Publication date
BR112012023232A2 (en) 2020-10-27
CN102883704A (en) 2013-01-16
JP2013522259A (en) 2013-06-13
US20130058990A1 (en) 2013-03-07
BR112012023232B1 (en) 2021-03-23
US9162976B2 (en) 2015-10-20
EP2547313A1 (en) 2013-01-23
US20160058682A1 (en) 2016-03-03

Similar Documents

Publication Publication Date Title
US9162976B2 (en) Composition containing a dibenzoylmethane screening agent and a hydrophilic or water-soluble merocyanin uv-screening agent; process for photostabilizing the dibenzoylmethane screening agent
AU2012285709B2 (en) Cosmetic and/or dermatological composition containing a merocyanine derivative comprising specific polar groups consisting of hydroxyl- and ether-functionalities
JP5866305B2 (en) Composition comprising dibenzoylmethane blocker and merocyanine dicyano or cyanoacetate derivative, and method for light stabilization of dibenzoylmethane blocker
US20080019930A1 (en) Dibenzoylmethane sunscreens photostabilized with arylalkyl amide or ester compounds
US7364721B2 (en) Photostabilization of dibenzoylmethane UV-screening agents with arylalkyl benzoate compounds and photoprotective cosmetic compositions comprised thereof
FR2977490A1 (en) PHOTOPROTECTIVE COMPOSITION
US20100003207A1 (en) Photoprotective compositions comprising photosensitive 1,3,5-triazine compounds, dibenzoylmethane compounds and siliceous s-triazines substituted with two aminobenzoate or aminobenzamide groups
US20070218022A1 (en) Photostable sunscreen compositions comprising cinnamic acid ester UV-B filters, dibenzoylmethane UV-A filters and s-triazine compounds
US20080317685A1 (en) Photoprotective cosmetic compositions comprising photostabilized dibenzoylmethane compounds and siloxane-containing arylalkyl benzoate amide compounds
WO2007080053A2 (en) Cosmetic composition containing a dibenzoylmethane derivative and a phenol or bisphenol compound; process for photostabilization of the dibenzoylmethane derivative
WO2011080043A1 (en) Ureidopyrimidones; cosmetic use as uv-screening agents; antisun compositions containing them
US9526924B2 (en) Composition comprising a screening agent of the lipophilic 2-hydroxybenzophenone type and a silicon-compromising s-triazine substituted by at least two alkylaminobenzoate groups
WO2007080052A1 (en) Cosmectic composition containing a dibenzoylmethane derivative and a siloxane-containing phenol or bisphenol compound; process for photostabilization of the dibenzoylmethane derivative
EP1815884A2 (en) Compositions containing an UV-B filter of the cinnamic acid ester type, a UV-A filter of the dibenzoylmethane type and a derivative of s-triazine; process of photostabilisation
EP1815886A2 (en) Compositions containing a UV-A filter of the dibenzoylmethane type and a s-triazine derivative; process of photostabilisation
US20080008669A1 (en) Photostable sunscreen compositions comprising cinnamate ester UV-B filters and s-triazine compounds
FR2902652A1 (en) Cosmetic composition comprises a dibenzoylmethane UV-A filter and an aromatic ester
EP1649900A2 (en) Light screening composition comprising a derivative of dibenzoylmethane, a bis-resorcinyl triazine and a compound capable of accepting energy of the excited triplet state of dibenzoylmethane; process for photostabilisation
US20080138303A1 (en) Photoprotective cosmetic compositions comprising silicon-containing s-triazine compounds substituted with two aminobenzoate or aminobenzamide groups and non-silicon-containing lipophilic triazine compound UV-screening agents
JP4713251B2 (en) Method for photoprotecting dibenzoylmethane derivatives using arylalkyl benzoate derivatives and bis-resorcinyltriazine compounds, and photoprotective compositions
US20070196294A1 (en) Photostable sunscreen compositions comprising dibenzoylmethane compound UV-A filters and s-triazine compounds
WO2012119860A1 (en) Cosmetic composition containing a dibenzoylmethane derivative and a monoester-monoamide compound of methylsuccinic acid; process for photostabilizing a dibenzoylmethane derivative
EP1911438A2 (en) Cosmetic composition containing a derivative of dibenzoylmethane and a arylalkyl amide or ester compound; method of photostabilising the derivative of dibenzoylmethane
FR2902650A1 (en) Cosmetic composition comprises a dibenzoylmethane UV-A filter and an aromatic amide
FR2888113A1 (en) Cosmetic composition to manufacture care, make-up and cosmetic products for skin, lips, nails, hair, lashes, eyebrows and/or scalp, comprises a benzylidene compound in a medium

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201180024051.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11706614

Country of ref document: EP

Kind code of ref document: A1

REEP Request for entry into the european phase

Ref document number: 2011706614

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2011706614

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2012557477

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112012023232

Country of ref document: BR

WWE Wipo information: entry into national phase

Ref document number: 13634194

Country of ref document: US

REG Reference to national code

Ref country code: BR

Ref legal event code: B01E

Ref document number: 112012023232

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112012023232

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20120914